TWI841655B - Organic light emitting device, manufacturing method of the same and composition for organic material layer of organic light emitting device - Google Patents
Organic light emitting device, manufacturing method of the same and composition for organic material layer of organic light emitting device Download PDFInfo
- Publication number
- TWI841655B TWI841655B TW108148067A TW108148067A TWI841655B TW I841655 B TWI841655 B TW I841655B TW 108148067 A TW108148067 A TW 108148067A TW 108148067 A TW108148067 A TW 108148067A TW I841655 B TWI841655 B TW I841655B
- Authority
- TW
- Taiwan
- Prior art keywords
- substituted
- unsubstituted
- chemical formula
- group
- same
- Prior art date
Links
- 239000011368 organic material Substances 0.000 title claims abstract description 63
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 19
- 239000000126 substance Substances 0.000 claims abstract description 174
- 150000002391 heterocyclic compounds Chemical class 0.000 claims abstract description 64
- 238000000034 method Methods 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims description 92
- 150000001875 compounds Chemical class 0.000 claims description 90
- 125000003118 aryl group Chemical group 0.000 claims description 86
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 70
- 229910052739 hydrogen Inorganic materials 0.000 claims description 70
- 239000001257 hydrogen Substances 0.000 claims description 70
- 125000001072 heteroaryl group Chemical group 0.000 claims description 60
- 125000000217 alkyl group Chemical group 0.000 claims description 34
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 33
- 229910052805 deuterium Inorganic materials 0.000 claims description 33
- 238000002347 injection Methods 0.000 claims description 30
- 239000007924 injection Substances 0.000 claims description 30
- 125000000623 heterocyclic group Chemical group 0.000 claims description 28
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 23
- 230000027756 respiratory electron transport chain Effects 0.000 claims description 19
- 125000003342 alkenyl group Chemical group 0.000 claims description 18
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 18
- 239000000758 substrate Substances 0.000 claims description 18
- 125000003545 alkoxy group Chemical group 0.000 claims description 16
- 230000000903 blocking effect Effects 0.000 claims description 16
- 125000000304 alkynyl group Chemical group 0.000 claims description 15
- 125000002950 monocyclic group Chemical group 0.000 claims description 13
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 12
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- 150000002367 halogens Chemical class 0.000 claims description 12
- 125000003367 polycyclic group Chemical group 0.000 claims description 12
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical class P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 7
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical group [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 238000001771 vacuum deposition Methods 0.000 claims description 4
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims 5
- 239000010410 layer Substances 0.000 description 126
- -1 C20 alkylamine Chemical class 0.000 description 77
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 66
- 125000001424 substituent group Chemical group 0.000 description 53
- 238000002360 preparation method Methods 0.000 description 37
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 29
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 22
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 20
- 125000004122 cyclic group Chemical group 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 125000004432 carbon atom Chemical group C* 0.000 description 16
- 238000000151 deposition Methods 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 238000005137 deposition process Methods 0.000 description 12
- 239000012153 distilled water Substances 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 235000010290 biphenyl Nutrition 0.000 description 10
- 239000004305 biphenyl Substances 0.000 description 10
- 230000008021 deposition Effects 0.000 description 10
- 239000000543 intermediate Substances 0.000 description 10
- 150000004945 aromatic hydrocarbons Chemical group 0.000 description 9
- 239000010409 thin film Substances 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- 125000004988 dibenzothienyl group Chemical group C1(=CC=CC=2SC3=C(C21)C=CC=C3)* 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 238000004770 highest occupied molecular orbital Methods 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 6
- 150000002739 metals Chemical class 0.000 description 6
- 125000001624 naphthyl group Chemical group 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000002019 doping agent Substances 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 5
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 229940126062 Compound A Drugs 0.000 description 4
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 229940125904 compound 1 Drugs 0.000 description 4
- 229920001940 conductive polymer Polymers 0.000 description 4
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical group C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 4
- 239000010408 film Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 229920000767 polyaniline Polymers 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- STTGYIUESPWXOW-UHFFFAOYSA-N 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline Chemical compound C=12C=CC3=C(C=4C=CC=CC=4)C=C(C)N=C3C2=NC(C)=CC=1C1=CC=CC=C1 STTGYIUESPWXOW-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000009477 glass transition Effects 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 125000001041 indolyl group Chemical group 0.000 description 3
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 125000006836 terphenylene group Chemical group 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- ODHXBMXNKOYIBV-UHFFFAOYSA-N triphenylamine Chemical compound C1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-N 0.000 description 3
- YBONBWJSFMTXLE-UHFFFAOYSA-N 2,3-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(Cl)=C1Cl YBONBWJSFMTXLE-UHFFFAOYSA-N 0.000 description 2
- DDGPPAMADXTGTN-UHFFFAOYSA-N 2-chloro-4,6-diphenyl-1,3,5-triazine Chemical compound N=1C(Cl)=NC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 DDGPPAMADXTGTN-UHFFFAOYSA-N 0.000 description 2
- 125000005916 2-methylpentyl group Chemical group 0.000 description 2
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 2
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 2
- KUBSCXXKQGDPPD-UHFFFAOYSA-N 3-bromo-9-phenylcarbazole Chemical compound C12=CC=CC=C2C2=CC(Br)=CC=C2N1C1=CC=CC=C1 KUBSCXXKQGDPPD-UHFFFAOYSA-N 0.000 description 2
- AWXGSYPUMWKTBR-UHFFFAOYSA-N 4-carbazol-9-yl-n,n-bis(4-carbazol-9-ylphenyl)aniline Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(N(C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=C1 AWXGSYPUMWKTBR-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- TUXZHAPTXYIMQK-UHFFFAOYSA-N ClC1=C(C(=CC=C1)OC)OB(O)O Chemical compound ClC1=C(C(=CC=C1)OC)OB(O)O TUXZHAPTXYIMQK-UHFFFAOYSA-N 0.000 description 2
- IZKFWMQDRUIMST-UHFFFAOYSA-N ClC=1C=C2C=3C=C4C(=CC3N(C2=CC1)C1=CC=CC=C1)N(C=1C=CC=CC14)C1=CC=CC=C1 Chemical compound ClC=1C=C2C=3C=C4C(=CC3N(C2=CC1)C1=CC=CC=C1)N(C=1C=CC=CC14)C1=CC=CC=C1 IZKFWMQDRUIMST-UHFFFAOYSA-N 0.000 description 2
- AFICSVORSKTVHB-UHFFFAOYSA-N ClC=1C=C2C=3C=C4C(=CC3NC2=CC1)N(C=1C=CC=CC14)C1=CC=CC=C1 Chemical compound ClC=1C=C2C=3C=C4C(=CC3NC2=CC1)N(C=1C=CC=CC14)C1=CC=CC=C1 AFICSVORSKTVHB-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- ZEEBGORNQSEQBE-UHFFFAOYSA-N [2-(3-phenylphenoxy)-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound C1(=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)C1=CC=CC=C1 ZEEBGORNQSEQBE-UHFFFAOYSA-N 0.000 description 2
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 239000010405 anode material Substances 0.000 description 2
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000010406 cathode material Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000005945 imidazopyridyl group Chemical group 0.000 description 2
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- IBHBKWKFFTZAHE-UHFFFAOYSA-N n-[4-[4-(n-naphthalen-1-ylanilino)phenyl]phenyl]-n-phenylnaphthalen-1-amine Chemical compound C1=CC=CC=C1N(C=1C2=CC=CC=C2C=CC=1)C1=CC=C(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C3=CC=CC=C3C=CC=2)C=C1 IBHBKWKFFTZAHE-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000002207 thermal evaporation Methods 0.000 description 2
- 238000002411 thermogravimetry Methods 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 125000004306 triazinyl group Chemical group 0.000 description 2
- 238000002061 vacuum sublimation Methods 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BHSJHAIXABJMSL-UHFFFAOYSA-N 1,1'-spirobi[benzo[b][1]benzosilole] Chemical compound C12=C3C=CC=CC3=[SiH]C2=CC=CC11C2=C3C=CC=CC3=[SiH]C2=CC=C1 BHSJHAIXABJMSL-UHFFFAOYSA-N 0.000 description 1
- ZIZMDHZLHJBNSQ-UHFFFAOYSA-N 1,2-dihydrophenazine Chemical compound C1=CC=C2N=C(C=CCC3)C3=NC2=C1 ZIZMDHZLHJBNSQ-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical group C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 1
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical group C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 1
- RKWWASUTWAFKHA-UHFFFAOYSA-N 1-bromo-2,3-difluorobenzene Chemical compound FC1=CC=CC(Br)=C1F RKWWASUTWAFKHA-UHFFFAOYSA-N 0.000 description 1
- MGHBDQZXPCTTIH-UHFFFAOYSA-N 1-bromo-2,4-difluorobenzene Chemical compound FC1=CC=C(Br)C(F)=C1 MGHBDQZXPCTTIH-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- IKBYTZCDHKXANH-UHFFFAOYSA-N 1-chloro-2-(2,3-difluorophenyl)-3-methoxybenzene Chemical group COc1cccc(Cl)c1-c1cccc(F)c1F IKBYTZCDHKXANH-UHFFFAOYSA-N 0.000 description 1
- JDZRLTYUHWKGIY-UHFFFAOYSA-N 1-chloro-2-(2,4-difluorophenyl)-3-methoxybenzene Chemical group ClC1=C(C(=CC=C1)OC)C1=C(C=C(C=C1)F)F JDZRLTYUHWKGIY-UHFFFAOYSA-N 0.000 description 1
- KFFJESFQFFREHN-UHFFFAOYSA-N 1-chloro-6-fluorodibenzofuran Chemical compound ClC1=CC=CC=2OC3=C(C=21)C=CC=C3F KFFJESFQFFREHN-UHFFFAOYSA-N 0.000 description 1
- AEQOXKLNJGVYMK-UHFFFAOYSA-N 1-chloro-7-fluorodibenzofuran Chemical compound ClC1=CC=CC=2OC3=C(C=21)C=CC(=C3)F AEQOXKLNJGVYMK-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- VFBJMPNFKOMEEW-UHFFFAOYSA-N 2,3-diphenylbut-2-enedinitrile Chemical group C=1C=CC=CC=1C(C#N)=C(C#N)C1=CC=CC=C1 VFBJMPNFKOMEEW-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- MZSAMHOCTRNOIZ-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-phenylaniline Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(NC2=CC=CC=C2)C=CC=1 MZSAMHOCTRNOIZ-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000006027 3-methyl-1-butenyl group Chemical group 0.000 description 1
- DDTHMESPCBONDT-UHFFFAOYSA-N 4-(4-oxocyclohexa-2,5-dien-1-ylidene)cyclohexa-2,5-dien-1-one Chemical class C1=CC(=O)C=CC1=C1C=CC(=O)C=C1 DDTHMESPCBONDT-UHFFFAOYSA-N 0.000 description 1
- 125000004920 4-methyl-2-pentyl group Chemical group CC(CC(C)*)C 0.000 description 1
- DIVZFUBWFAOMCW-UHFFFAOYSA-N 4-n-(3-methylphenyl)-1-n,1-n-bis[4-(n-(3-methylphenyl)anilino)phenyl]-4-n-phenylbenzene-1,4-diamine Chemical compound CC1=CC=CC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)N(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)=C1 DIVZFUBWFAOMCW-UHFFFAOYSA-N 0.000 description 1
- XDDAUUXEDWARAT-UHFFFAOYSA-N 5,7-diphenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolo[2,3-b]carbazole Chemical compound B1(OC(C(O1)(C)C)(C)C)C2=CC3=C(C=C2)N(C4=C3C=C5C6=CC=CC=C6N(C5=C4)C7=CC=CC=C7)C8=CC=CC=C8 XDDAUUXEDWARAT-UHFFFAOYSA-N 0.000 description 1
- MMXHPUBSLNWZEV-UHFFFAOYSA-N 5-chloro-2-(2,3-difluorophenyl)phenol Chemical compound ClC=1C=C(C(=CC=1)C1=C(C(=CC=C1)F)F)O MMXHPUBSLNWZEV-UHFFFAOYSA-N 0.000 description 1
- ATVCCTDTTGRCFX-UHFFFAOYSA-N 5-chloro-2-(2,4-difluorophenyl)phenol Chemical compound ClC=1C=C(C(=CC=1)C1=C(C=C(C=C1)F)F)O ATVCCTDTTGRCFX-UHFFFAOYSA-N 0.000 description 1
- BFMXBYPBWWMIPN-UHFFFAOYSA-N 5-phenyl-7h-indolo[2,3-b]carbazole Chemical compound C1=CC=CC=C1N1C2=CC(NC=3C4=CC=CC=3)=C4C=C2C2=CC=CC=C21 BFMXBYPBWWMIPN-UHFFFAOYSA-N 0.000 description 1
- ZSMRRZONCYIFNB-UHFFFAOYSA-N 6,11-dihydro-5h-benzo[b][1]benzazepine Chemical group C1CC2=CC=CC=C2NC2=CC=CC=C12 ZSMRRZONCYIFNB-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- IPTBCVPDIQFYCA-UHFFFAOYSA-N 9-(9-chlorodibenzofuran-3-yl)carbazole Chemical compound ClC1=CC=CC2=C1C1=C(O2)C=C(C=C1)N1C2=CC=CC=C2C=2C=CC=CC1=2 IPTBCVPDIQFYCA-UHFFFAOYSA-N 0.000 description 1
- MRTBHNLSHRIIMJ-UHFFFAOYSA-N 9-(9-chlorodibenzofuran-4-yl)carbazole Chemical compound C1=C(N2C3=C(C=CC=C3)C3=C2C=CC=C3)C=2OC3=C(C=2C=C1)C(=CC=C3)Cl MRTBHNLSHRIIMJ-UHFFFAOYSA-N 0.000 description 1
- SMFVCHCLYWMCDO-UHFFFAOYSA-N 9-[9-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzofuran-3-yl]carbazole Chemical compound CC1(OB(OC1(C)C)C1=CC=CC2=C1C1=C(O2)C=C(C=C1)N1C2=CC=CC=C2C=2C=CC=CC1=2)C SMFVCHCLYWMCDO-UHFFFAOYSA-N 0.000 description 1
- IOHHWTTYXRHHGJ-UHFFFAOYSA-N 9-[9-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzofuran-4-yl]carbazole Chemical compound CC1(OB(OC1(C)C)C1=CC=CC2=C1C1=C(O2)C(=CC=C1)N1C2=CC=CC=C2C=2C=CC=CC1=2)C IOHHWTTYXRHHGJ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000284156 Clerodendrum quadriloculare Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- 101000837344 Homo sapiens T-cell leukemia translocation-altered gene protein Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910006404 SnO 2 Inorganic materials 0.000 description 1
- 102100028692 T-cell leukemia translocation-altered gene protein Human genes 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- SLGBZMMZGDRARJ-UHFFFAOYSA-N Triphenylene Chemical group C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C2=C1 SLGBZMMZGDRARJ-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- SAHIZENKTPRYSN-UHFFFAOYSA-N [2-[3-(phenoxymethyl)phenoxy]-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound O(C1=CC=CC=C1)CC=1C=C(OC2=NC(=CC(=C2)CN)C(F)(F)F)C=CC=1 SAHIZENKTPRYSN-UHFFFAOYSA-N 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- HAQFCILFQVZOJC-UHFFFAOYSA-N anthracene-9,10-dione;methane Chemical compound C.C.C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 HAQFCILFQVZOJC-UHFFFAOYSA-N 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 1
- LPTWEDZIPSKWDG-UHFFFAOYSA-N benzenesulfonic acid;dodecane Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCCCCCCCCCCC LPTWEDZIPSKWDG-UHFFFAOYSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000006616 biphenylamine group Chemical group 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001716 carbazoles Chemical class 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- 125000005266 diarylamine group Chemical group 0.000 description 1
- 125000005331 diazinyl group Chemical group N1=NC(=CC=C1)* 0.000 description 1
- 125000005509 dibenzothiophenyl group Chemical group 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 125000005303 dithiazolyl group Chemical group S1SNC(=C1)* 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000008376 fluorenones Chemical class 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- RBTKNAXYKSUFRK-UHFFFAOYSA-N heliogen blue Chemical compound [Cu].[N-]1C2=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=NC([N-]1)=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=N2 RBTKNAXYKSUFRK-UHFFFAOYSA-N 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 229910003437 indium oxide Inorganic materials 0.000 description 1
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- FQKSBRCHLNOAGY-UHFFFAOYSA-N indolo[2,3-a]carbazole Chemical group C1=CC=C2N=C3C4=NC5=CC=CC=C5C4=CC=C3C2=C1 FQKSBRCHLNOAGY-UHFFFAOYSA-N 0.000 description 1
- HLYDAUPLQZMMTR-UHFFFAOYSA-N indolo[2,3-b]carbazole Chemical group N1=C2C=CC=CC2=C2C1=CC1=NC3=CC=CC=C3C1=C2 HLYDAUPLQZMMTR-UHFFFAOYSA-N 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- DCZNSJVFOQPSRV-UHFFFAOYSA-N n,n-diphenyl-4-[4-(n-phenylanilino)phenyl]aniline Chemical class C1=CC=CC=C1N(C=1C=CC(=CC=1)C=1C=CC(=CC=1)N(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 DCZNSJVFOQPSRV-UHFFFAOYSA-N 0.000 description 1
- BSEKBMYVMVYRCW-UHFFFAOYSA-N n-[4-[3,5-bis[4-(n-(3-methylphenyl)anilino)phenyl]phenyl]phenyl]-3-methyl-n-phenylaniline Chemical compound CC1=CC=CC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=C(C=C(C=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)=C1 BSEKBMYVMVYRCW-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000004866 oxadiazoles Chemical class 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 description 1
- ASUOLLHGALPRFK-UHFFFAOYSA-N phenylphosphonoylbenzene Chemical group C=1C=CC=CC=1P(=O)C1=CC=CC=C1 ASUOLLHGALPRFK-UHFFFAOYSA-N 0.000 description 1
- 125000004585 polycyclic heterocycle group Chemical group 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000128 polypyrrole Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 150000003219 pyrazolines Chemical class 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical compound COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical group C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005247 tetrazinyl group Chemical group N1=NN=NC(=C1)* 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- JFLKFZNIIQFQBS-FNCQTZNRSA-N trans,trans-1,4-Diphenyl-1,3-butadiene Chemical group C=1C=CC=CC=1\C=C\C=C\C1=CC=CC=C1 JFLKFZNIIQFQBS-FNCQTZNRSA-N 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005580 triphenylene group Chemical group 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- UGOMMVLRQDMAQQ-UHFFFAOYSA-N xphos Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 UGOMMVLRQDMAQQ-UHFFFAOYSA-N 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- YVTHLONGBIQYBO-UHFFFAOYSA-N zinc indium(3+) oxygen(2-) Chemical compound [O--].[Zn++].[In+3] YVTHLONGBIQYBO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
Landscapes
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Optics & Photonics (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
Description
本申請案主張於2018年12月28日向韓國智慧財產局提出申請的韓國專利申請案第10-2018-0172503號的優先權及權益,所述韓國專利申請案的全部內容併入本案供參考。 This application claims the priority and rights of Korean Patent Application No. 10-2018-0172503 filed with the Korean Intellectual Property Office on December 28, 2018. The entire contents of the Korean Patent Application are incorporated into this application for reference.
本說明書是有關於一種有機發光裝置、一種用於製造有機發光裝置的方法以及一種用於有機發光裝置之有機材料層的組成物。 This specification relates to an organic light-emitting device, a method for manufacturing an organic light-emitting device, and a composition of an organic material layer for an organic light-emitting device.
電致發光(electroluminescent,EL)裝置是一種自發光顯示裝置,且優點是具有寬視角及高響應速度,且具有極佳對比度。 Electroluminescent (EL) devices are self-luminous display devices with the advantages of wide viewing angles, high response speeds, and excellent contrast.
一種有機發光裝置具有在兩個電極之間設置有機薄膜的結構。當向具有此種結構的有機發光裝置施加電壓時,自所述兩 個電極注入的電子與電洞在有機薄膜中連結成對,且當該些電子及電洞湮滅時,會有光發出。有機薄膜可視需要以單層或多層形成。 An organic light-emitting device has a structure in which an organic thin film is disposed between two electrodes. When a voltage is applied to the organic light-emitting device having such a structure, electrons and holes injected from the two electrodes are paired in the organic thin film, and when the electrons and holes annihilate, light is emitted. The organic thin film can be formed in a single layer or multiple layers as needed.
有機薄膜的材料可視需要具有發光功能。舉例而言,作為有機薄膜的材料,可僅使用能夠形成發光層的化合物,或者亦可使用能夠發揮基於主體摻雜劑的發光層的主體或摻雜劑作用的化合物。除此之外,能夠發揮電洞注入、電洞轉移、電子阻擋、電洞阻擋、電子轉移、電子注入等作用的化合物亦可用作有機薄膜的材料。 The material of the organic thin film may have a light-emitting function as required. For example, as the material of the organic thin film, only compounds that can form a light-emitting layer can be used, or compounds that can play the role of the host or dopant of the light-emitting layer based on the host dopant can also be used. In addition, compounds that can play the role of hole injection, hole transfer, electron blocking, hole blocking, electron transfer, electron injection, etc. can also be used as materials for organic thin films.
為增強有機發光裝置的效能、壽命或效率,一直不斷地需要開發有機薄膜材料。 There is a continuous need to develop organic thin film materials to enhance the performance, lifetime or efficiency of organic light-emitting devices.
美國專利第4,356,429號 U.S. Patent No. 4,356,429
本申請案是有關於一種有機發光裝置、一種用於製造有機發光裝置的方法以及一種用於有機材料層的組成物。 This application relates to an organic light-emitting device, a method for manufacturing an organic light-emitting device, and a composition for an organic material layer.
本申請案的一個實施例提供一種有機發光裝置,所述有機發光裝置包括:第一電極;第二電極;以及一或多個有機材料層,設 置於所述第一電極與所述第二電極之間,其中所述一或多個有機材料層包含由以下化學式1表示的雜環化合物及由以下化學式2表示的雜環化合物。 An embodiment of the present application provides an organic light-emitting device, the organic light-emitting device comprising: a first electrode; a second electrode; and one or more organic material layers disposed between the first electrode and the second electrode, wherein the one or more organic material layers contain a heterocyclic compound represented by the following chemical formula 1 and a heterocyclic compound represented by the following chemical formula 2.
在化學式1及化學式2中,N-Het為經取代或未經取代的單環或多環雜環基,且包括一或多個N,L為直接鍵;經取代或未經取代的伸芳基;或者經取代或未經取代的伸雜芳基,a為1至3的整數,且當a為2或大於2時, L彼此相同或彼此不同,R1至R19彼此相同或彼此不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的烷基;經取代或未經取代的烯基;經取代或未經取代的炔基;經取代或未經取代的烷氧基;經取代或未經取代的環烷基;經取代或未經取代的雜環烷基;經取代或未經取代的芳基;經取代或未經取代的雜芳基;經取代或未經取代的氧化膦基;以及經取代或未經取代的胺基,或者彼此相鄰的二或更多個基團彼此鍵合以形成經取代或未經取代的脂肪族或芳香族烴環或經取代或未經取代的雜環,b及c各自為1至3的整數,d為0至2的整數,且當b為2或大於2時,R9彼此相同或彼此不同,當c為2或大於2時,R10彼此相同或彼此不同,且當d為整數2時,R19彼此相同或彼此不同,A1與A2彼此相同或彼此不同,且各自獨立地為O;S;NRa;或者CRbRc,並且Ra至Rc彼此相同或彼此不同,且各自獨立地為氫;經取代或未經取代的烷基;經取代或未經取代的芳基;或者經取代或未經取代的雜芳基。 In Formula 1 and Formula 2, N-Het is a substituted or unsubstituted monocyclic or polycyclic heterocyclic group and includes one or more N, L is a direct bond; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group, a is an integer from 1 to 3, and when a is 2 or greater, L is the same as or different from each other, R 1 to R 19 are the same as or different from each other and are each independently selected from the group consisting of: hydrogen; deuterium; halogen; cyano; substituted or unsubstituted alkyl; substituted or unsubstituted alkenyl; substituted or unsubstituted alkynyl; substituted or unsubstituted alkoxy; substituted or unsubstituted cycloalkyl; substituted or unsubstituted heterocycloalkyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; substituted or unsubstituted phosphine oxide; and substituted or unsubstituted amine, or two or more adjacent groups are bonded to each other to form a substituted or unsubstituted aliphatic or aromatic hydrocarbon ring or a substituted or unsubstituted heterocyclic ring, b and c are each an integer from 1 to 3, d is an integer from 0 to 2, and when b is 2 or greater, R wherein R 9 are the same as or different from each other, when c is 2 or greater, R 10 are the same as or different from each other, and when d is an integer of 2, R 19 are the same as or different from each other, A 1 and A 2 are the same as or different from each other and are each independently O; S; NR a ; or CR b R c , and R a to R c are the same as or different from each other and are each independently hydrogen; substituted or unsubstituted alkyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl.
另外,本申請案的另一實施例提供一種用於有機發光裝置的有機材料層的組成物,所述組成物包含由化學式1表示的所述雜環化合物及由化學式2表示的所述雜環化合物。 In addition, another embodiment of the present application provides a composition for an organic material layer of an organic light-emitting device, wherein the composition comprises the heterocyclic compound represented by Chemical Formula 1 and the heterocyclic compound represented by Chemical Formula 2.
最後,本申請案的一個實施例提供一種用於製造有機發光裝置的方法,所述方法包括:製備基板;在所述基板上形成第一 電極;在所述第一電極上形成一或多個有機材料層;以及在所述有機材料層上形成第二電極,其中所述形成有機材料層包括使用根據本申請案的用於有機材料層的組成物形成一或多個有機材料層。 Finally, an embodiment of the present application provides a method for manufacturing an organic light-emitting device, the method comprising: preparing a substrate; forming a first electrode on the substrate; forming one or more organic material layers on the first electrode; and forming a second electrode on the organic material layer, wherein the forming of the organic material layer comprises forming one or more organic material layers using the composition for the organic material layer according to the present application.
根據本申請案的一個實施例的雜環化合物可用作有機發光裝置的有機材料層的材料。雜環化合物可用作有機發光裝置中的電洞注入層、電洞轉移層、發光層、電子轉移層、電子注入層、電荷產生層等的材料。具體而言,由化學式1表示的雜環化合物與由化學式2表示的化合物可同時用作有機發光裝置的發光層的材料。另外,當同時在有機發光裝置中使用由化學式1表示的雜環化合物及由化學式2表示的雜環化合物時,可降低裝置的驅動電壓,可提高光效率,且可藉由化合物的熱穩定性來提高裝置的壽命性質。 According to an embodiment of the present application, the heterocyclic compound can be used as a material for an organic material layer of an organic light-emitting device. The heterocyclic compound can be used as a material for a hole injection layer, a hole transfer layer, a light-emitting layer, an electron transfer layer, an electron injection layer, a charge generation layer, etc. in an organic light-emitting device. Specifically, the heterocyclic compound represented by Chemical Formula 1 and the compound represented by Chemical Formula 2 can be used simultaneously as materials for the light-emitting layer of an organic light-emitting device. In addition, when the heterocyclic compound represented by Chemical Formula 1 and the heterocyclic compound represented by Chemical Formula 2 are used simultaneously in an organic light-emitting device, the driving voltage of the device can be reduced, the light efficiency can be improved, and the life properties of the device can be improved by the thermal stability of the compound.
具體而言,在由化學式1表示的雜環化合物中,藉由二苯並呋喃結構的1號碳位被含N環取代且二苯並呋喃結構中未被含N環取代的苯被咔唑結構取代,獲得了電子更穩定的結構,且因此,可提高裝置壽命。 Specifically, in the heterocyclic compound represented by Chemical Formula 1, by replacing the carbon position 1 of the dibenzofuran structure with an N-containing ring and replacing the benzene in the dibenzofuran structure that is not replaced by the N-containing ring with a carbazole structure, a more electronically stable structure is obtained, and thus, the device life can be improved.
100:基板 100: Substrate
200:陽極 200: Yang pole
300:有機材料層 300: Organic material layer
301:電洞注入層 301: Hole injection layer
302:電洞轉移層 302: Hole transfer layer
303:發光層 303: Luminous layer
304:電洞阻擋層 304: Hole blocking layer
305:電子轉移層 305:Electron transfer layer
306:電子注入層 306: Electron injection layer
400:陰極 400: cathode
圖1至圖3是各自示意性示出根據本申請案一個實施例的有機發光裝置的層壓結構的圖。 Figures 1 to 3 are diagrams each schematically showing a laminated structure of an organic light-emitting device according to an embodiment of the present application.
圖4及圖5是示出本申請案的化合物2-19的熱穩定性的曲線 圖。 Figures 4 and 5 are graphs showing the thermal stability of compound 2-19 of the present application.
圖6及圖7是示出本申請案的化合物2-20的熱穩定性的曲線圖。 Figures 6 and 7 are graphs showing the thermal stability of compound 2-20 of the present application.
圖8及圖9是示出本申請案的化合物2-22的熱穩定性的曲線圖。 Figures 8 and 9 are graphs showing the thermal stability of compound 2-22 of the present application.
圖10及圖11是示出本申請案的化合物2-8的熱穩定性的曲線圖。 Figures 10 and 11 are graphs showing the thermal stability of compound 2-8 of the present application.
圖12及圖13是示出本申請案的化合物2-18的熱穩定性的曲線圖。 Figures 12 and 13 are graphs showing the thermal stability of compound 2-18 of the present application.
圖14及圖15是示出本申請案的化合物2-79的熱穩定性的曲線圖。 Figures 14 and 15 are graphs showing the thermal stability of compound 2-79 of the present application.
圖16及圖17是示出本申請案的化合物2-123的熱穩定性的曲線圖。 Figures 16 and 17 are graphs showing the thermal stability of compound 2-123 of the present application.
圖18及圖19是示出化合物A的熱穩定性的曲線圖。 Figures 18 and 19 are graphs showing the thermal stability of compound A.
圖20及圖21是示出化合物C的熱穩定性的曲線圖。 Figures 20 and 21 are graphs showing the thermal stability of compound C.
在下文中,將詳細闡述本申請案。 This application will be described in detail below.
用語「取代(substitution)」意指鍵合至化合物的碳原子的氫原子改變為另一取代基,且取代位置不受限制,只要其為氫原子被取代的位置(即取代基可進行取代的位置)即可,且當二或更多個取代基進行取代時,所述二或更多個取代基可彼此相同或彼 此不同。 The term "substitution" means that a hydrogen atom bonded to a carbon atom of a compound is changed to another substituent, and the substitution position is not limited as long as it is a position where a hydrogen atom is substituted (i.e., a position where a substituent can be substituted), and when two or more substituents are substituted, the two or more substituents can be the same as or different from each other.
在本說明書中,「經取代或未經取代的(substituted or unsubstituted)」意指被選自由C1至C60直鏈或支鏈烷基;C2至C60直鏈或支鏈烯基;C2至C60直鏈或支鏈炔基;C3至C60單環或多環環烷基;C2至C60單環或多環雜環烷基;C6至C60單環或多環芳基;C2至C60單環或多環雜芳基;-SiRR'R";-P(=O)RR';C1至C20烷基胺;C6至C60單環或多環芳基胺;以及C2至C60單環或多環雜芳基胺組成的群組的一或多個取代基取代或未經取代,或者被與選自以上所示的取代基的二或多個取代基聯結的取代基取代或未經取代。R、R'及R"彼此相同或彼此不同,且各自獨立地為氫;氘;氰基;經取代或未經取代的烷基;經取代或未經取代的環烷基;經取代或未經取代的芳基;或者經取代或未經取代的雜芳基。 In the present specification, "substituted or unsubstituted" means a group selected from C1 to C60 straight or branched alkyl; C2 to C60 straight or branched alkenyl; C2 to C60 straight or branched alkynyl; C3 to C60 monocyclic or polycyclic cycloalkyl; C2 to C60 monocyclic or polycyclic heterocyclic alkyl; C6 to C60 monocyclic or polycyclic aryl; C2 to C60 monocyclic or polycyclic heteroaryl; -SiRR'R"; -P(=O)RR'; C1 to C20 alkylamine; C6 to C60 monocyclic or polycyclic heterocyclic alkyl; Cycloarylamine; and C2 to C60 monocyclic or polycyclic heteroarylamines, which are substituted or unsubstituted with one or more substituents, or substituted or unsubstituted with substituents linked to two or more substituents selected from the substituents shown above. R, R' and R" are the same or different from each other, and are each independently hydrogen; deuterium; cyano; substituted or unsubstituted alkyl; substituted or unsubstituted cycloalkyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl.
在本申請案的一個實施例中,R、R'及R"彼此相同或彼此不同,且可各自獨立地為氫;經取代或未經取代的烷基;經取代或未經取代的芳基;或者經取代或未經取代的雜芳基。 In one embodiment of the present application, R, R' and R" are the same or different from each other, and can be independently hydrogen; substituted or unsubstituted alkyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl.
在本說明書中,鹵素可為氟、氯、溴或碘。 In this specification, halogen can be fluorine, chlorine, bromine or iodine.
在本說明書中,烷基包括具有1至60個碳原子的直鏈或支鏈烷基,且可進一步被其他取代基取代。烷基的碳原子的數目可為1至60、具體為1至40且更具體為1至20。烷基的具體實例可包括甲基、乙基、丙基、正丙基、異丙基、丁基、正丁基、異丁基、第三丁基、第二丁基、1-甲基-丁基、1-乙基-丁基、戊基、 正戊基、異戊基、新戊基、第三戊基、己基、正己基、1-甲基戊基、2-甲基戊基、4-甲基-2-戊基、3,3-二甲基丁基、2-乙基丁基、庚基、正庚基、1-甲基己基、環戊基甲基、環己基甲基、辛基、正辛基、第三辛基、1-甲基庚基、2-乙基己基、2-丙基戊基、正壬基、2,2-二甲基庚基、1-乙基丙基、1,1-二甲基丙基、異己基、2-甲基戊基、4-甲基己基、5-甲基己基等,但不限於此。 In the present specification, the alkyl group includes a straight or branched alkyl group having 1 to 60 carbon atoms, and may be further substituted with other substituents. The number of carbon atoms of the alkyl group may be 1 to 60, specifically 1 to 40, and more specifically 1 to 20. Specific examples of the alkyl group may include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, tert-butyl, 1-methyl-butyl, 1-ethyl-butyl, pentyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, hexyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 4-methyl-2-pentyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl, n-heptyl, 1-methylhexyl, cyclopentylmethyl, cyclohexylmethyl, octyl, n-octyl, tert-octyl, 1-methylheptyl, 2-ethylhexyl, 2-propylpentyl, n-nonyl, 2,2-dimethylheptyl, 1-ethylpropyl, 1,1-dimethylpropyl, isohexyl, 2-methylpentyl, 4-methylhexyl, 5-methylhexyl, etc., but are not limited thereto.
在本說明書中,烯基包括具有2至60個碳原子的直鏈或支鏈烯基,且可進一步被其他取代基取代。烯基的碳原子的數目可為2至60、具體為2至40且更具體為2至20。烯基的具體實例可包括乙烯基、1-丙烯基、異丙烯基、1-丁烯基、2-丁烯基、3-丁烯基、1-戊烯基、2-戊烯基、3-戊烯基、3-甲基-1-丁烯基、1,3-丁二烯基、烯丙基、1-苯基乙烯基-1-基、2-苯基乙烯基-1-基、2,2-二苯基乙烯基-1-基、2-苯基-2-(萘基-1-基)乙烯基-1-基、2,2-雙(二苯基-1-基)乙烯基-1-基、二苯乙烯基、苯乙烯基等,但不限於此。 In the present specification, alkenyl includes straight or branched alkenyl having 2 to 60 carbon atoms, and may be further substituted by other substituents. The number of carbon atoms of the alkenyl may be 2 to 60, specifically 2 to 40 and more specifically 2 to 20. Specific examples of alkenyl may include vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 3-methyl-1-butenyl, 1,3-butadienyl, allyl, 1-phenylvinyl-1-yl, 2-phenylvinyl-1-yl, 2,2-diphenylvinyl-1-yl, 2-phenyl-2-(naphthyl-1-yl)vinyl-1-yl, 2,2-bis(diphenyl-1-yl)vinyl-1-yl, distyryl, styryl, etc., but are not limited thereto.
在本說明書中,炔基包括具有2至60個碳原子的直鏈或支鏈炔基,且可進一步被其他取代基取代。炔基的碳原子的數目可為2至60、具體為2至40且更具體為2至20。 In the present specification, the alkynyl group includes a straight chain or branched chain alkynyl group having 2 to 60 carbon atoms, and may be further substituted by other substituents. The number of carbon atoms of the alkynyl group may be 2 to 60, specifically 2 to 40, and more specifically 2 to 20.
在本說明書中,烷氧基可為直鏈、支鏈或環狀的。烷氧基的碳原子的數目無特別限制,但較佳為1至20。烷氧基的具體實例可包括甲氧基、乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第三丁氧基、第二丁氧基、正戊氧基、新戊氧基、異戊氧基、正己氧基、3,3-二甲基丁氧基、2-乙基丁氧基、正辛氧基、正 壬氧基、正癸氧基、苄氧基、對甲基苄氧基等,但不限於此。 In the present specification, the alkoxy group may be linear, branched or cyclic. The number of carbon atoms of the alkoxy group is not particularly limited, but is preferably 1 to 20. Specific examples of the alkoxy group may include methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentoxy, neopentoxy, isopentoxy, n-hexoxy, 3,3-dimethylbutoxy, 2-ethylbutoxy, n-octoxy, n-nonoxy, n-decyloxy, benzyloxy, p-methylbenzyloxy, etc., but are not limited thereto.
在本說明書中,環烷基包括具有3至60個碳原子的單環或多環環烷基,且可進一步被其他取代基取代。在本文中,多環意指環烷基直接聯結至其他環狀基團或與其他環狀基團稠合的基團。在本文中,其他環狀基團可為環烷基,但亦可為例如雜環烷基、芳基及雜芳基等不同類型的環狀基團。環烷基的碳原子的數目可為3至60、具體為3至40且更具體為5至20。環烷基的具體實例可包括環丙基、環丁基、環戊基、3-甲基環戊基、2,3-二甲基環戊基、環己基、3-甲基環己基、4-甲基環己基、2,3-二甲基環己基、3,4,5-三甲基環己基、4-第三丁基環己基、環庚基、環辛基等,但不限於此。 In this specification, cycloalkyl includes monocyclic or polycyclic cycloalkyl with 3 to 60 carbon atoms, and can be further substituted by other substituents. In this article, polycyclic means that cycloalkyl is directly connected to other cyclic groups or groups fused with other cyclic groups. In this article, other cyclic groups can be cycloalkyl, but can also be different types of cyclic groups such as heterocycloalkyl, aryl and heteroaryl. The number of carbon atoms of cycloalkyl can be 3 to 60, specifically 3 to 40 and more specifically 5 to 20. Specific examples of cycloalkyl groups may include cyclopropyl, cyclobutyl, cyclopentyl, 3-methylcyclopentyl, 2,3-dimethylcyclopentyl, cyclohexyl, 3-methylcyclohexyl, 4-methylcyclohexyl, 2,3-dimethylcyclohexyl, 3,4,5-trimethylcyclohexyl, 4-tert-butylcyclohexyl, cycloheptyl, cyclooctyl, etc., but are not limited thereto.
在本說明書中,雜環烷基包括作為雜原子的O、S、Se、N或Si,包括具有2至60個碳原子的單環或多環雜環烷基,且可進一步被其他取代基取代。在本文中,多環意指雜環烷基直接聯結至其他環狀基團或與其他環狀基團稠合的基團。在本文中,其他環狀基團可為雜環烷基,但亦可為例如環烷基、芳基及雜芳基等不同類型的環狀基團。雜環烷基的碳原子的數目可為2至60、具體為2至40且更具體為3至20。 In the present specification, heterocycloalkyl includes O, S, Se, N or Si as a hetero atom, including monocyclic or polycyclic heterocycloalkyl having 2 to 60 carbon atoms, and may be further substituted by other substituents. In this article, polycyclic means a heterocycloalkyl directly linked to other cyclic groups or fused with other cyclic groups. In this article, other cyclic groups may be heterocycloalkyl, but may also be different types of cyclic groups such as cycloalkyl, aryl and heteroaryl. The number of carbon atoms of the heterocycloalkyl may be 2 to 60, specifically 2 to 40 and more specifically 3 to 20.
在本說明書中,芳基包括具有6至60個碳原子的單環或多環芳基,且可進一步被其他取代基取代。在本文中,多環意指芳基直接聯結至其他環狀基團或與其他環狀基團稠合的基團。在本文中,其他環狀基團可為芳基,但亦可為例如環烷基、雜環烷基 及雜芳基等不同類型的環狀基團。芳基包括螺基。芳基的碳原子的數目可為6至60、具體為6至40且更具體為6至25。芳基的具體實例可包括苯基、聯苯基、三苯基、萘基、蒽基、基、菲基、苝基、茀蒽基、三伸苯基、萉基、芘基、稠四苯基、稠五苯基、芴基、茚基、苊基、苯並芴基、螺二芴基、2,3-二氫-1H-茚基、其稠環等,但不限於此。 In the present specification, aryl includes monocyclic or polycyclic aryl having 6 to 60 carbon atoms, and may be further substituted by other substituents. In this article, polycyclic means that aryl is directly linked to other cyclic groups or groups condensed with other cyclic groups. In this article, other cyclic groups may be aryl, but may also be different types of cyclic groups such as cycloalkyl, heterocycloalkyl and heteroaryl. Aryl includes spiro. The number of carbon atoms of aryl may be 6 to 60, specifically 6 to 40 and more specifically 6 to 25. Specific examples of aryl may include phenyl, biphenyl, triphenyl, naphthyl, anthracenyl, 1H-indenyl, 2,3-dihydro-1H-indenyl, and fused rings thereof.
在本說明書中,芴基可被取代,且相鄰的取代基可彼此鍵合以形成環。 In this specification, the fluorenyl group may be substituted, and adjacent substituents may bond to each other to form a ring.
當芴基被取代時,可包括、、、、、等,然而,所述結構不限於此。 When the fluorenyl group is substituted, it may include , , , , , Etc., however, the structure is not limited thereto.
在本說明書中,雜芳基包括作為雜原子的O、S、Se、N或Si,包括具有2至60個碳原子的單環或多環雜芳基,且可進一步被其他取代基取代。在本文中,多環意指雜芳基直接聯結至其他環狀基團或與其他環狀基團稠合的基團。在本文中,其他環狀基團可為雜芳基,但亦可為例如環烷基、雜環烷基及芳基等不同類型的環狀基團。雜芳基的碳原子的數目可為2至60、具體為2至40且更具體為3至25。雜芳基的具體實例可包括吡啶基、吡咯基、嘧啶基、噠嗪基、呋喃基、噻吩基、咪唑基、吡唑基、噁唑基、異噁 唑基、噻唑基、異噻唑基、三唑基、呋呫基、噁二唑基、噻二唑基、二噻唑基、四唑基、吡喃基、噻喃基、二嗪基、嗪基、噻嗪基、二氧雜環己烯基(dioxynyl group)、三嗪基(triazinyl group)、四嗪基(tetrazinyl group)、喹啉基、異喹啉基、喹唑啉基、異喹唑啉基、喹嗪啉基(qninozolinyl group)、氮雜萘基(naphthyridyl group)、吖啶基、啡啶基(phenanthridinyl group)、咪唑並吡啶基、二氮亞萘基(diazanaphthalenyl group)、三氮茚基、吲哚基、吲哚嗪基、苯並噻唑基、苯並噁唑基、苯並咪唑基、苯並噻吩基、苯並呋喃基、二苯並噻吩基、二苯並呋喃基、咔唑基、苯並咔唑基、二苯並咔唑基、吩嗪基、二苯並噻咯基(dibenzosilole group)、螺二(二苯並噻咯)(spirobi(dibenzosilole))、二氫吩嗪基、吩嗪基、啡啶基(phenanthridyl group)、咪唑並吡啶基、噻吩基、吲哚並[2,3-a]咔唑基、吲哚並[2,3-b]咔唑基、吲哚啉基、10,11-二氫二苯並[b,f]氮呼基、9,10-二氫吖啶基、菲嗪基(phenanthrazinyl group)、啡噻嗪基、呔嗪基、萘啶基、菲咯啉基(phenanthrolinyl group)、苯並[c][1,2,5]噻二唑基、5,10-二氫苯並[b,e][1,4]氮雜矽烷啉基(5,10-dihydrobenzo[b,e][1,4]azasilinyl)、吡唑並[1,5-c]喹唑啉基、吡啶並[1,2-b]吲哚基、吡啶並[1,2-a]咪唑並[1,2-e]吲哚基、5,11-二氫茚並[1,2-b]咔唑基等,但不限於此。 In this specification, heteroaryl includes O, S, Se, N or Si as heteroatoms, including monocyclic or polycyclic heteroaryl with 2 to 60 carbon atoms, and can be further substituted by other substituents. In this article, polycyclic means that heteroaryl is directly connected to other cyclic groups or groups fused with other cyclic groups. In this article, other cyclic groups can be heteroaryl, but can also be different types of cyclic groups such as cycloalkyl, heterocycloalkyl and aryl. The number of carbon atoms of heteroaryl can be 2 to 60, specifically 2 to 40 and more specifically 3 to 25. Specific examples of heteroaryl groups may include pyridyl, pyrrolyl, pyrimidinyl, oxazinyl, furanyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, furazanyl, oxadiazolyl, thiadiazolyl, dithiazolyl, tetrazolyl, pyranyl, thiopyranyl, diazinyl, azinyl group, a thiazinyl group, a dioxynyl group, a triazinyl group, a tetrazinyl group, a quinolyl group, an isoquinolyl group, a quinazolyl group, an isoquinazolyl group, a quinozolinyl group, a naphthyridyl group, an acridinyl group, a phenanthridinyl group, an imidazopyridyl group, a diazanaphthalenyl group, a triazinyl group, an indolyl group, an indolizinyl group, a benzothiazolyl group, a benzoxazolyl group, a benzimidazolyl group, a benzothiophenyl group, a benzofuranyl group, a dibenzothiophenyl group, a dibenzofuranyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a phenazinyl group, a dibenzosilole ... group), spirobi(dibenzosilole), dihydrophenazine, phen azine group, phenanthridyl group, imidazopyridyl group, thienyl group, indolo[2,3-a]carbazole group, indolo[2,3-b]carbazole group, indolinyl group, 10,11-dihydrodibenzo[b,f]azepine group, 9,10-dihydroacridinyl group, phenanthrazinyl group, phenathrazinyl group, phenathiazinyl group, phenazine group, naphthyridinyl group, phenanthrolinyl group group), benzo[c][1,2,5]thiadiazolyl, 5,10-dihydrobenzo[b,e][1,4]azasilinyl, pyrazolo[1,5-c]quinazolinyl, pyrido[1,2-b]indolyl, pyrido[1,2-a]imidazo[1,2-e]indolyl, 5,11-dihydroindeno[1,2-b]carbazolyl, etc., but are not limited thereto.
在本說明書中,胺基可選自由以下組成的群組:單烷基胺基;單芳基胺基;單雜芳基胺基;-NH2;二烷基胺基;二芳基胺基;二雜芳基胺基;烷基芳基胺基;烷基雜芳基胺基;以及芳基雜 芳基胺基團,且儘管不特別限於此,然而碳原子的數目較佳為1至30。胺基的具體實例可包括甲基胺基、二甲基胺基、乙基胺基、二乙基胺基、苯基胺基、萘基胺基、聯苯基胺基、二聯苯基胺基、蒽基胺基、9-甲基-蒽基胺基、二苯基胺基、苯基萘基胺基、二甲苯基胺基、苯基甲苯基胺基、三苯基胺基、聯苯基萘基胺基、苯基聯苯基胺基、聯苯基芴基胺基、苯基三伸苯基胺基、聯苯基三伸苯基胺基等,但不限於此。 In the present specification, the amine group may be selected from the group consisting of monoalkylamine, monoarylamine, monoheteroarylamine, -NH2 , dialkylamine, diarylamine, diheteroarylamine, alkylarylamine, alkylheteroarylamine, and arylheteroarylamine groups, and although not particularly limited thereto, the number of carbon atoms is preferably 1 to 30. Specific examples of the amino group may include methylamino, dimethylamino, ethylamino, diethylamino, phenylamino, naphthylamino, biphenylamino, diphenylamino, anthracenylamino, 9-methyl-anthrylamino, diphenylamino, phenylnaphthylamino, ditolylamino, phenyltolylamino, triphenylamino, biphenylnaphthylamino, phenylbiphenylamino, biphenylfluorenylamino, phenyltriphenylamino, biphenyltriphenylamino, and the like, but are not limited thereto.
在本說明書中,伸芳基意指具有兩個鍵合位點的芳基,即二價基團。對以上所提供的芳基的說明可應用於伸芳基,各自為二價者除外。另外,伸雜芳基意指具有兩個鍵合位點的雜芳基,即二價基團。對以上所提供的雜芳基的說明可應用於伸雜芳基,各自為二價者除外。 In this specification, an aryl group refers to an aryl group having two bonding sites, i.e., a divalent group. The description of the aryl group provided above can be applied to aryl groups, except that each of them is divalent. In addition, a heteroaryl group refers to a heteroaryl group having two bonding sites, i.e., a divalent group. The description of the heteroaryl group provided above can be applied to heteroaryl groups, except that each of them is divalent.
在本說明書中,氧化膦基由-P(=O)R101R102表示,且R101與R102彼此相同或彼此不同,且可各自獨立地為由以下中的至少一者形成的取代基:氫;氘;鹵素基;烷基;烯基;烷氧基;環烷基;芳基;以及雜環基。具體而言,氧化膦基可具體地被芳基取代,且作為芳基,可使用上述實例。氧化膦基的實例可包括二苯基氧化膦基、二萘基氧化膦基等,但不限於此。 In the present specification, the phosphine oxide group is represented by -P(=O)R 101 R 102 , and R 101 and R 102 are the same as or different from each other, and can each independently be a substituent formed by at least one of the following: hydrogen; deuterium; halogen group; alkyl group; alkenyl group; alkoxy group; cycloalkyl group; aryl group; and heterocyclic group. Specifically, the phosphine oxide group can be specifically substituted by an aryl group, and as the aryl group, the above examples can be used. Examples of the phosphine oxide group can include a diphenylphosphine oxide group, a dinaphthylphosphine oxide group, etc., but are not limited thereto.
在本說明書中,矽烷基是包括Si的取代基,具有作為自由基而直接聯結的Si原子,且由-SiR104R105R106表示。R104至R106彼此相同或彼此不同,且可各自獨立地為由以下中的至少一者形成的取代基:氫;氘;鹵素基;烷基;烯基;烷氧基;環烷基;芳 基;以及雜環基。矽烷基的具體實例可包括三甲基矽烷基、三乙基矽烷基、第三丁基二甲基矽烷基、乙烯基二甲基矽烷基、丙基二甲基矽烷基、三苯基矽烷基、二苯基矽烷基、苯基矽烷基等,但不限於此。 In the present specification, a silyl group is a substituent including Si, has a Si atom directly bonded as a free radical, and is represented by -SiR104R105R106. R104 to R106 are the same as or different from each other, and may each independently be a substituent formed of at least one of the following: hydrogen; deuterium; halogen group; alkyl group; alkenyl group; alkoxy group; cycloalkyl group; aryl group; and heterocyclic group. Specific examples of the silyl group may include trimethylsilyl group, triethylsilyl group, tert-butyldimethylsilyl group, vinyldimethylsilyl group, propyldimethylsilyl group, triphenylsilyl group, diphenylsilyl group, phenylsilyl group, and the like, but are not limited thereto.
在本說明書中,「相鄰」基團可意指取代與被對應取代基取代的原子直接聯結的原子的取代基、在空間上位置最靠近對應取代基的取代基或者取代被對應取代基取代的原子的另一取代基。舉例而言,取代苯環中鄰位的兩個取代基以及取代脂肪族環中同一碳的兩個取代基可解釋為彼此「相鄰」的基團。 In this specification, "adjacent" groups may refer to substituents that replace atoms directly connected to the atoms substituted by the corresponding substituents, substituents that are spatially closest to the corresponding substituents, or another substituent that replaces the atoms substituted by the corresponding substituents. For example, two substituents that replace adjacent positions in a benzene ring and two substituents that replace the same carbon in an aliphatic ring can be interpreted as groups that are "adjacent" to each other.
作為相鄰基團可形成的脂肪族或芳香族烴環或雜環,可使用以上所述的作為環烷基、環雜烷基、芳基及雜芳基示出的結構,非單價者除外。 As aliphatic or aromatic hydrocarbon rings or heterocyclic rings that can be formed by adjacent groups, the structures shown above as cycloalkyl, cycloheteroalkyl, aryl and heteroaryl can be used, except for non-monovalent ones.
本申請案的一個實施例提供一種有機發光裝置,所述有機發光裝置包括:第一電極;第二電極;以及一或多個有機材料層,設置於第一電極與第二電極之間,其中所述一或多個有機材料層包含由化學式1表示的雜環化合物及由化學式2表示的雜環化合物。 An embodiment of the present application provides an organic light-emitting device, the organic light-emitting device comprising: a first electrode; a second electrode; and one or more organic material layers disposed between the first electrode and the second electrode, wherein the one or more organic material layers contain a heterocyclic compound represented by Chemical Formula 1 and a heterocyclic compound represented by Chemical Formula 2.
在本申請案的一個實施例中,化學式1可由以下化學式3至化學式6中的一者表示。 In one embodiment of the present application, Chemical Formula 1 can be represented by one of the following Chemical Formulas 3 to 6.
[化學式3]
[化學式5]
在化學式3至化學式6中,取代基具有與化學式1中的定義相同的定義。 In Chemical Formulae 3 to 6, the substituents have the same definitions as those in Chemical Formula 1.
在本申請案的一個實施例中,N-Het為經取代或未經取代的單環或多環雜環,且包括一或多個N。 In one embodiment of the present application, N-Het is a substituted or unsubstituted monocyclic or polycyclic heterocyclic ring and includes one or more N.
在另一實施例中,N-Het為未經取代的或被一或多個選自由芳基及雜芳基組成的群組的取代基取代的單環或多環雜環,且包括一或多個N。 In another embodiment, N-Het is a monocyclic or polycyclic heterocyclic ring which is unsubstituted or substituted by one or more substituents selected from the group consisting of aryl and heteroaryl, and includes one or more N.
在另一實施例中,N-Het為未經取代的或被選自由苯基、 聯苯基、萘基、二甲基芴基、二苯並呋喃基及二苯並噻吩基組成的群組的一或多個取代基取代的單環或多環雜環,且包括一或多個N。 In another embodiment, N-Het is a monocyclic or polycyclic heterocyclic ring which is unsubstituted or substituted by one or more substituents selected from the group consisting of phenyl, biphenyl, naphthyl, dimethylfluorenyl, dibenzofuranyl and dibenzothienyl, and includes one or more N.
在另一實施例中,N-Het為未經取代的或被選自由苯基、聯苯基、萘基、二甲基芴基、二苯並呋喃基及二苯並噻吩基組成的群組的一或多個取代基取代的單環或多環雜環,且包括一或多個N且包括三或更少個N。 In another embodiment, N-Het is a monocyclic or polycyclic heterocyclic ring which is unsubstituted or substituted by one or more substituents selected from the group consisting of phenyl, biphenyl, naphthyl, dimethylfluorenyl, dibenzofuranyl and dibenzothienyl, and includes one or more N and includes three or less N.
在本申請案的一個實施例中,N-Het為經取代或未經取代的單環雜環,且包括一或多個N。 In one embodiment of the present application, N-Het is a substituted or unsubstituted monocyclic heterocyclic ring and includes one or more N.
在本申請案的一個實施例中,N-Het為經取代或未經取代的二價或更高價雜環,且包括一或多個N。 In one embodiment of the present application, N-Het is a substituted or unsubstituted divalent or higher valent heterocyclic ring and includes one or more N.
在本申請案的一個實施例中,N-Het為經取代或未經取代的單環或多環雜環,且包括二或更多個N。 In one embodiment of the present application, N-Het is a substituted or unsubstituted monocyclic or polycyclic heterocyclic ring and includes two or more N.
在本申請案的一個實施例中,N-Het為包括二或更多個N的二價或更高價多環雜環。 In one embodiment of the present application, N-Het is a divalent or higher valent polycyclic heterocycle including two or more Ns.
在本申請案的一個實施例中,化學式1由以下化學式7至化學式9中的一者表示。 In one embodiment of the present application, Chemical Formula 1 is represented by one of the following Chemical Formulas 7 to 9.
[化學式7]
[化學式9]
在化學式7至化學式9中,X1為CR21或N,X2為CR22或N,X3為CR23或N,X4為CR24或N,且X5為CR25或N,且R21至R25及R27至R32彼此相同或彼此不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的烷基;經取代或未經取代的烯基;經取代或未經取代的炔基;經取代或未經取代的烷氧基;經取代或未經取代的環烷基;經取代或未經取代的雜環烷基;經取代或未經取代的芳基;經取代或未經取代的雜芳基;經取代或未經取代的氧化膦基;以及經取代或未經取代的胺基,或者彼此相鄰的二或更多個基團彼此鍵合以形成經取代或未經取代的脂肪族或芳香族烴環或雜環。 In Chemical Formulae 7 to 9, X1 is CR21 or N, X2 is CR22 or N, X3 is CR23 or N, X4 is CR24 or N, and X5 is CR25 or N, and R21 to R25 and R27 to R32 are the same as or different from each other, and are each independently selected from the group consisting of: hydrogen; deuterium; halogen; cyano; substituted or unsubstituted alkyl; substituted or unsubstituted alkenyl; substituted or Unsubstituted alkynyl; substituted or unsubstituted alkoxy; substituted or unsubstituted cycloalkyl; substituted or unsubstituted heterocycloalkyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; substituted or unsubstituted phosphine oxide; and substituted or unsubstituted amine, or two or more adjacent groups bond to each other to form a substituted or unsubstituted aliphatic or aromatic hydrocarbon ring or heterocycle.
在本申請案的一個實施例中,可由以下化學式10至化學式13中的一者表示。在本文中,為聯結至L的位點。 In one embodiment of the present application, It can be represented by one of the following chemical formulas 10 to 13. Herein, is the site for attachment to L.
[化學式13]
在化學式10中,X1、X3及X5中的一或多者為N,且其餘者具有與化學式7中的定義相同的定義,在化學式11中,X1、X2及X5中的一或多者為N,且其餘者具有與化學式7中的定義相同的定義,在化學式12中,X1至X3中的一或多者為N,且其餘者具有與化學式7中的定義相同的定義,在化學式13中,X1、X2及X5中的一或多者為N,且其餘者具有與化學式7中的定義相同的定義,且R22、R24及R33至R36彼此相同或彼此不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的烷基;經取代或未經取代的烯基;經取代或未經取代的炔基;經取代或未經取代的烷氧基;經取代或未經取代的環烷基;經取代或未經取代的雜環烷基;經取代或未經取代的芳基;經取代或未經取代的雜芳基;經取代或未經取代的氧化膦基;以及經取代或未經取代的胺基,或者彼此相鄰的二或更多個基團彼此鍵合以形成經取代或未經取代的脂肪族或芳香族烴環或雜環。 In Chemical Formula 10, one or more of X1, X3 and X5 is N, and the rest have the same definition as in Chemical Formula 7. In Chemical Formula 11, one or more of X1, X2 and X5 is N, and the rest have the same definition as in Chemical Formula 7. In Chemical Formula 12, one or more of X1 to X3 is N, and the rest have the same definition as in Chemical Formula 7. In Chemical Formula 13, one or more of X1, X2 and X5 is N, and the rest have the same definition as in Chemical Formula 7. R22, R24 and R33 to R36 are the same as each other or different from each other. This is different from and each is independently selected from the group consisting of: hydrogen; deuterium; halogen; cyano; substituted or unsubstituted alkyl; substituted or unsubstituted alkenyl; substituted or unsubstituted alkynyl; substituted or unsubstituted alkoxy; substituted or unsubstituted cycloalkyl; substituted or unsubstituted heterocycloalkyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; substituted or unsubstituted phosphine oxide; and substituted or unsubstituted amine, or two or more adjacent groups are bonded to each other to form a substituted or unsubstituted aliphatic or aromatic hydrocarbon ring or heterocycle.
在本申請案的一個實施例中,化學式10可選自以下結構式。 In one embodiment of the present application, chemical formula 10 can be selected from the following structural formulas.
在結構式中,每一取代基具有與化學式10中的定義相同的定義。 In the structural formula, each substituent has the same definition as in Chemical Formula 10.
在本申請案的一個實施例中,化學式11可由以下化學式14表示。 In one embodiment of the present application, Chemical Formula 11 can be represented by the following Chemical Formula 14.
化學式14中的取代基具有與化學式11中的定義相同的定義。 The substituents in Chemical Formula 14 have the same definitions as those in Chemical Formula 11.
在本申請案的一個實施例中,化學式12可由以下化學式15表示。 In one embodiment of the present application, Chemical Formula 12 can be represented by the following Chemical Formula 15.
[化學式15]
化學式15中的取代基具有與化學式12中的定義相同的定義。 The substituents in Chemical Formula 15 have the same definitions as those in Chemical Formula 12.
在本申請案的一個實施例中,化學式11可由以下化學式16表示。 In one embodiment of the present application, Chemical Formula 11 can be represented by the following Chemical Formula 16.
在化學式16中,R37彼此相同或彼此不同,且選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的烷基;經取代或未經取代的烯基;經取代或未經取代的炔基;經取代或未經取代的烷氧基;經取代或未經取代的環烷基;經取代或未經取代的雜環烷基;經取代或未經取代的芳基;經取代或未經取代的雜芳基;經取代或未經取 代的氧化膦基;以及經取代或未經取代的胺基,或者彼此相鄰的二或更多個基團彼此鍵合以形成經取代或未經取代的脂肪族或芳香族烴環或雜環,e為0至7的整數,且當e為2或大於2時,R37彼此相同或彼此不同。 In Chemical Formula 16, R37 are the same as or different from each other and are selected from the group consisting of: hydrogen; deuterium; halogen; cyano; substituted or unsubstituted alkyl; substituted or unsubstituted alkenyl; substituted or unsubstituted alkynyl; substituted or unsubstituted alkoxy; substituted or unsubstituted cycloalkyl; substituted or unsubstituted heterocycloalkyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; substituted or unsubstituted phosphine oxide; and substituted or unsubstituted amine, or two or more groups adjacent to each other are bonded to each other to form a substituted or unsubstituted aliphatic or aromatic hydrocarbon or heterocyclic ring, e is an integer from 0 to 7, and when e is 2 or greater than 2, R37 are the same as or different from each other.
在本申請案的一個實施例中,化學式13可由以下化學式17表示。 In one embodiment of the present application, Chemical Formula 13 can be represented by the following Chemical Formula 17.
化學式17中的取代基具有與化學式13中的定義相同的定義。 The substituents in Chemical Formula 17 have the same definitions as those in Chemical Formula 13.
在另一實施例中,L為直接鍵或伸芳基。 In another embodiment, L is a direct bond or an aryl group.
在另一實施例中,L為直接鍵或伸苯基。 In another embodiment, L is a direct bond or a phenyl group.
在另一實施例中,R9及R10為氫;或者氘。 In another embodiment, R9 and R10 are hydrogen; or deuterium.
在另一實施例中,R9及R10為氫。 In another embodiment, R9 and R10 are hydrogen.
在另一實施例中,R1至R8為氫;氘;未經取代的或被烷基、芳基或雜芳基取代的芳基;或者未經取代的或被芳基或雜芳基取代的雜芳基。 In another embodiment, R1 to R8 are hydrogen; deuterium; unsubstituted or substituted aryl with alkyl, aryl or heteroaryl; or unsubstituted or substituted heteroaryl with aryl or heteroaryl.
在另一實施例中,R1至R8為氫;氘;芳基;雜芳基; 或者被芳基取代的雜芳基。 In another embodiment, R1 to R8 are hydrogen; deuterium; aryl; heteroaryl; or heteroaryl substituted by aryl.
在另一實施例中,R1至R8為氫;氘;苯基;二苯並呋喃基;二苯並噻吩基;咔唑基;或者被苯基取代的咔唑基。 In another embodiment, R1 to R8 are hydrogen; deuterium; phenyl; dibenzofuranyl; dibenzothienyl; carbazolyl; or carbazolyl substituted with phenyl.
在另一實施例中,R1至R8為氫;氘;苯基;二苯並呋喃基;或者被苯基取代的咔唑基。 In another embodiment, R1 to R8 are hydrogen; deuterium; phenyl; dibenzofuranyl; or carbazolyl substituted with phenyl.
在另一實施例中,R1至R8中相鄰的二或更多個取代基彼此鍵合以形成經取代或未經取代的環。 In another embodiment, two or more adjacent substituents in R1 to R8 are bonded to each other to form a substituted or unsubstituted ring.
在另一實施例中,R1至R8中相鄰的二或更多個取代基彼此鍵合以形成未經取代的或被芳基或烷基取代的環。 In another embodiment, two or more adjacent substituents in R1 to R8 are bonded to each other to form a ring that is unsubstituted or substituted with an aryl or alkyl group.
在另一實施例中,R1至R8中相鄰的二或更多個取代基彼此鍵合以形成未經取代的或被芳基或烷基取代的芳香族烴環或雜環。 In another embodiment, two or more adjacent substituents in R1 to R8 are bonded to each other to form an aromatic hydrocarbon ring or heterocyclic ring which is unsubstituted or substituted with an aryl group or an alkyl group.
在另一實施例中,R1至R8中相鄰的二或更多個取代基彼此鍵合以形成未經取代的或被苯基或甲基取代的芳香族烴環或雜環。 In another embodiment, two or more adjacent substituents in R1 to R8 are bonded to each other to form an aromatic hydrocarbon ring or heterocyclic ring which is unsubstituted or substituted with a phenyl group or a methyl group.
在另一實施例中,R1至R8中相鄰的二或更多個取代基彼此鍵合以形成苯環;未經取代的或被苯基取代的吲哚環;苯並噻吩環;苯並呋喃環;或未經取代的或被甲基取代的茚環。 In another embodiment, two or more adjacent substituents in R1 to R8 are bonded to each other to form a benzene ring; an unsubstituted or phenyl-substituted indole ring; a benzothiophene ring; a benzofuran ring; or an unsubstituted or methyl-substituted indene ring.
在另一實施例中,可由以下化學式18表示。在本文中,為聯結至二苯並呋喃結構的位點。 In another embodiment, It can be represented by the following chemical formula 18. In this article, is the site of attachment to the dibenzofuran structure.
在化學式18中,R1至R4具有與化學式1中的定義相同的定義,Y為O、S、NRd或CReRf,Rd、Re、Rf、R41及R42彼此相同或彼此不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的烷基;經取代或未經取代的烯基;經取代或未經取代的炔基;經取代或未經取代的烷氧基;經取代或未經取代的環烷基;經取代或未經取代的雜環烷基;經取代或未經取代的芳基;經取代或未經取代的雜芳基;經取代或未經取代的氧化膦基;以及經取代或未經 取代的胺基,或者彼此相鄰的二或更多個基團彼此鍵合以形成經取代或未經取代的脂肪族或芳香族烴環或經取代或未經取代的雜環,f為0至4的整數,且當f為2或大於2時,R41彼此相同或彼此不同,g為0至2的整數,且當g為2或大於2時,R42彼此相同或彼此不同。 In Chemical Formula 18, R1 to R4 have the same definitions as those in Chemical Formula 1, Y is O, S, NR d or CR e R f , R d , Re , R f , R41 and R42 are the same as or different from each other, and are each independently selected from the group consisting of: hydrogen; deuterium; halogen; cyano; substituted or unsubstituted alkyl; substituted or unsubstituted alkenyl; substituted or unsubstituted alkynyl; substituted or unsubstituted alkoxy; substituted or unsubstituted cycloalkyl; substituted or unsubstituted heterocycloalkyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; a substituted or unsubstituted phosphine oxide group; and a substituted or unsubstituted amine group, or two or more adjacent groups are bonded to each other to form a substituted or unsubstituted aliphatic or aromatic hydrocarbon ring or a substituted or unsubstituted heterocyclic ring, f is an integer from 0 to 4, and when f is 2 or greater than 2, R41 are the same as or different from each other, g is an integer from 0 to 2, and when g is 2 or greater than 2, R42 are the same as or different from each other.
在另一實施例中,化學式18可選自以下結構式。 In another embodiment, chemical formula 18 can be selected from the following structural formulas.
在結構式中,取代基具有與化學式18中的定義相同的定義。 In the structural formula, the substituents have the same definitions as in Chemical Formula 18.
在本申請案的一個實施例中,R28至R31彼此相同或彼此不同,且各自獨立地為氫;氘;芳基;或者雜芳基。 In one embodiment of the present application, R28 to R31 are the same as or different from each other, and each is independently hydrogen; deuterium; aryl; or heteroaryl.
在另一實施例中,R28至R31彼此相同或彼此不同,且各自獨立地為氫;或者氘。 In another embodiment, R28 to R31 are the same as or different from each other, and each is independently hydrogen; or deuterium.
在另一實施例中,R28至R31為氫。 In another embodiment, R28 to R31 are hydrogen.
在本申請案的一個實施例中,R27與R32彼此相同或彼 此不同,且各自獨立地為氫;氘;芳基;或者雜芳基。 In one embodiment of the present application, R27 and R32 are the same or different from each other, and are independently hydrogen; deuterium; aryl; or heteroaryl.
在另一實施例中,R27與R32彼此相同或彼此不同,且各自獨立地為芳基;或者雜芳基。 In another embodiment, R27 and R32 are the same or different from each other, and each is independently an aryl group; or a heteroaryl group.
在另一實施例中,R27與R32彼此相同或彼此不同,且各自獨立地為芳基。 In another embodiment, R27 and R32 are the same or different from each other, and each is independently an aryl group.
在另一實施例中,R27與R32為苯基。 In another embodiment, R27 and R32 are phenyl groups.
在本申請案的一個實施例中,R21至R25彼此相同或彼此不同,且各自獨立地為氫;氘;未經取代的或被烷基取代的芳基;或者經取代或未經取代的雜芳基。 In one embodiment of the present application, R21 to R25 are the same or different from each other, and are independently hydrogen; deuterium; unsubstituted or alkyl-substituted aryl; or substituted or unsubstituted heteroaryl.
在另一實施例中,R21至R25彼此相同或彼此不同,且各自獨立地為氫;氘;未經取代的或被烷基取代的芳基;或者雜芳基。 In another embodiment, R21 to R25 are the same as or different from each other, and are each independently hydrogen; deuterium; unsubstituted or alkyl-substituted aryl; or heteroaryl.
在另一實施例中,R21至R25彼此相同或彼此不同,且各自獨立地為氫;未經取代的或被甲基取代的芳基;或者雜芳基。 In another embodiment, R21 to R25 are the same as or different from each other, and are each independently hydrogen; an unsubstituted or methyl-substituted aryl; or a heteroaryl.
在另一實施例中,R21至R25彼此相同或彼此不同,且各自獨立地為氫;苯基;聯苯基;萘基;二甲基芴基;二苯並呋喃基;或者二苯並噻吩基。 In another embodiment, R21 to R25 are the same as or different from each other, and are each independently hydrogen; phenyl; biphenyl; naphthyl; dimethylfluorenyl; dibenzofuranyl; or dibenzothienyl.
在另一實施例中,R22與R24彼此相同或彼此不同,且各自獨立地為未經取代的或被烷基取代的芳基;或者雜芳基。 In another embodiment, R22 and R24 are the same or different from each other, and are each independently an unsubstituted or alkyl-substituted aryl group; or a heteroaryl group.
在另一實施例中,R22與R24彼此相同或彼此不同,且各自獨立地為苯基、聯苯基、萘基、二甲基芴基;二苯並呋喃基;或者二苯並噻吩基。 In another embodiment, R22 and R24 are the same or different from each other, and are each independently phenyl, biphenyl, naphthyl, dimethylfluorenyl; dibenzofuranyl; or dibenzothienyl.
在本申請案的一個實施例中,R33至R36彼此相同或彼此不同,且各自獨立地為氫;氘;芳基;或者雜芳基。 In one embodiment of the present application, R33 to R36 are the same as or different from each other, and each is independently hydrogen; deuterium; aryl; or heteroaryl.
在另一實施例中,R33至R36彼此相同或彼此不同,且各自獨立地為氫;氘;或者芳基。 In another embodiment, R33 to R36 are the same as or different from each other, and each is independently hydrogen; deuterium; or aryl.
在另一實施例中,R33至R36彼此相同或彼此不同,且各自獨立地為氫;或者芳基。 In another embodiment, R33 to R36 are the same as or different from each other, and each is independently hydrogen; or aryl.
在另一實施例中,R33至R36彼此相同或彼此不同,且各自獨立地為氫;苯基;或者聯苯基。 In another embodiment, R33 to R36 are the same as or different from each other, and each is independently hydrogen; phenyl; or biphenyl.
在本申請案的一個實施例中,R37為氫;氘;芳基;或者雜芳基。 In one embodiment of the present application, R37 is hydrogen; deuterium; aryl; or heteroaryl.
在另一實施例中,R37為氫;氘;或者芳基。 In another embodiment, R37 is hydrogen; deuterium; or aryl.
在另一實施例中,R37為氫;或者芳基。 In another embodiment, R37 is hydrogen; or aryl.
在另一實施例中,R37為氫;或者苯基。 In another embodiment, R37 is hydrogen; or phenyl.
在本申請案的一個實施例中,Y為O或S。 In one embodiment of the present application, Y is O or S.
在另一實施例中,Y為NRd,且Rd為芳基。 In another embodiment, Y is NR d , and R d is aryl.
在另一實施例中,Y為NRd,且Rd為苯基。 In another embodiment, Y is NR d and R d is phenyl.
在另一實施例中,Y為CReRf,且Re及Rf為烷基。 In another embodiment, Y is CR e R f , and Re and R f are alkyl.
在另一實施例中,Y為CReRf,且Re及Rf為甲基。 In another embodiment, Y is CR e R f , and Re and R f are methyl.
在本申請案的一個實施例中,R41為氫;氘;芳基;或者雜芳基。 In one embodiment of the present application, R41 is hydrogen; deuterium; aryl; or heteroaryl.
在另一實施例中,R41為氫;氘;或者芳基。 In another embodiment, R41 is hydrogen; deuterium; or aryl.
在另一實施例中,R41為氫;或者苯基。 In another embodiment, R41 is hydrogen; or phenyl.
在本申請案的一個實施例中,R42為氫;或者氘。 In one embodiment of the present application, R42 is hydrogen; or deuterium.
在另一實施例中,R42為氫。 In another embodiment, R42 is hydrogen.
在本申請案的一個實施例中,化學式2的A1與A2彼此相同或彼此不同,且可各自獨立地為O;S;NRa;或者CRbRc。 In one embodiment of the present application, A1 and A2 in Chemical Formula 2 are the same as or different from each other, and can be independently O; S; NR a ; or CR b R c .
在本申請案的一個實施例中,Ra至Rc彼此相同或彼此不同,且可各自獨立地為氫;經取代或未經取代的C1至C60烷基;經取代或未經取代的C6至C60芳基;或者經取代或未經取代的C2至C60雜芳基。 In one embodiment of the present application, Ra to Rc are the same as or different from each other, and may be independently hydrogen; a substituted or unsubstituted C1 to C60 alkyl group; a substituted or unsubstituted C6 to C60 aryl group; or a substituted or unsubstituted C2 to C60 heteroaryl group.
在另一實施例中,Ra至Rc彼此相同或彼此不同,且可各自獨立地為氫;經取代或未經取代的C1至C40烷基;經取代或未經取代的C6至C40芳基;或者經取代或未經取代的C2至C40雜芳基。 In another embodiment, Ra to Rc are the same as or different from each other, and may each independently be hydrogen; substituted or unsubstituted C1 to C40 alkyl; substituted or unsubstituted C6 to C40 aryl; or substituted or unsubstituted C2 to C40 heteroaryl.
在另一實施例中,Ra至Rc彼此相同或彼此不同,且可各自獨立地為氫;C1至C40烷基;未經取代的或被選自由C1至C40烷基、C6至C40芳基及三苯基矽烷基組成的群組的一或多個取代基取代的C6至C40芳基;或者未經取代的或被C6至C40芳基取代的C2至C40雜芳基。 In another embodiment, Ra to Rc are the same as or different from each other and may each independently be hydrogen; a C1 to C40 alkyl group; a C6 to C40 aryl group which is unsubstituted or substituted with one or more substituents selected from the group consisting of a C1 to C40 alkyl group, a C6 to C40 aryl group and a triphenylsilyl group; or a C2 to C40 heteroaryl group which is unsubstituted or substituted with a C6 to C40 aryl group.
在另一實施例中,Ra至Rc彼此相同或彼此不同,且可各自獨立地為甲基;未經取代的或被選自由苯基及三苯基矽烷基組成的群組的一或多個取代基取代的苯基;未經取代的或被苯基取代的聯苯基;萘基;三伸苯基;二苯基芴基;二甲基芴基;未經取代的或被苯基取代的咔唑基;二苯並呋喃基;或者二苯並噻吩 基。 In another embodiment, Ra to Rc are the same as or different from each other, and may be each independently methyl; phenyl which is unsubstituted or substituted by one or more substituents selected from the group consisting of phenyl and triphenylsilyl; biphenyl which is unsubstituted or substituted by phenyl; naphthyl; triphenylene; diphenylfluorenyl; dimethylfluorenyl; carbazolyl which is unsubstituted or substituted by phenyl; dibenzofuranyl; or dibenzothienyl.
在本申請案的一個實施例中,R11至R19彼此相同或彼此不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的烷基;經取代或未經取代的烯基;經取代或未經取代的炔基;經取代或未經取代的烷氧基;經取代或未經取代的環烷基;經取代或未經取代的雜環烷基;經取代或未經取代的芳基;經取代或未經取代的雜芳基;經取代或未經取代的氧化膦基;以及經取代或未經取代的胺基,或者彼此相鄰的二或更多個基團可彼此鍵合以形成經取代或未經取代的脂肪族或芳香族烴環或經取代或未經取代的雜環。 In one embodiment of the present application, R 11 to R 19 are the same as or different from each other, and are each independently selected from the group consisting of: hydrogen; deuterium; halogen; cyano; substituted or unsubstituted alkyl; substituted or unsubstituted alkenyl; substituted or unsubstituted alkynyl; substituted or unsubstituted alkoxy; substituted or unsubstituted cycloalkyl; substituted or unsubstituted heterocycloalkyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; substituted or unsubstituted phosphine oxide; and substituted or unsubstituted amine, or two or more groups adjacent to each other may be bonded to each other to form a substituted or unsubstituted aliphatic or aromatic hydrocarbon ring or a substituted or unsubstituted heterocyclic ring.
在另一實施例中,R11至R19彼此相同或彼此不同,且可各自獨立地為氫;經取代或未經取代的芳基;或者經取代或未經取代的雜芳基。 In another embodiment, R 11 to R 19 are the same as or different from each other, and may each independently be hydrogen; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl.
在另一實施例中,R11至R19彼此相同或彼此不同,且可各自獨立地為氫;經取代或未經取代的C6至C60芳基;或者經取代或未經取代的C2至C60雜芳基。 In another embodiment, R 11 to R 19 are the same as or different from each other, and may be each independently hydrogen; a substituted or unsubstituted C6 to C60 aryl group; or a substituted or unsubstituted C2 to C60 heteroaryl group.
在另一實施例中,R11至R19彼此相同或彼此不同,且可各自獨立地為氫;經取代或未經取代的C6至C40芳基;或者經取代或未經取代的C2至C40雜芳基。 In another embodiment, R 11 to R 19 are the same as or different from each other, and may be each independently hydrogen; a substituted or unsubstituted C6 to C40 aryl group; or a substituted or unsubstituted C2 to C40 heteroaryl group.
在另一實施例中,R11至R19彼此相同或彼此不同,且可各自獨立地為氫;C6至C40芳基;或者未經取代的或被C6至C40芳基取代的C2至C40雜芳基。 In another embodiment, R 11 to R 19 are the same as or different from each other, and may be each independently hydrogen; a C6 to C40 aryl group; or a C2 to C40 heteroaryl group which is unsubstituted or substituted with a C6 to C40 aryl group.
在另一實施例中,R11至R19彼此相同或彼此不同,且可各自獨立地為氫;苯基;三伸苯基;未經取代的或被苯基或聯苯基取代的咔唑基;二苯並呋喃基;或者二苯並噻吩基。 In another embodiment, R 11 to R 19 are the same as or different from each other, and may be each independently hydrogen; phenyl; terphenylene; carbazolyl which is unsubstituted or substituted with phenyl or biphenyl; dibenzofuranyl; or dibenzothienyl.
在本申請案的一個實施例中,R15至R19可為氫。 In one embodiment of the present application, R 15 to R 19 may be hydrogen.
在本申請案的一個實施例中,R11及R14可為氫。 In one embodiment of the present application, R 11 and R 14 may be hydrogen.
在本申請案的一個實施例中,R12與R13彼此相同或彼此不同,且可各自獨立地為氫;苯基;三伸苯基;未經取代的或被苯基或聯苯基取代的咔唑基;二苯並呋喃基;或者二苯並噻吩基。 In one embodiment of the present application, R 12 and R 13 are the same as or different from each other, and can be independently hydrogen; phenyl; terphenylene; unsubstituted or substituted carbazolyl with phenyl or biphenyl; dibenzofuranyl; or dibenzothienyl.
在本申請案的一個實施例中,化學式2可由以下化學式2-1至化學式2-6中的任一者表示。 In one embodiment of the present application, Chemical Formula 2 can be represented by any one of the following Chemical Formulas 2-1 to 2-6.
[化學式2-2]
在化學式2-1至化學式2-6中,R11至R19、A1、A2及d具有與化學式2中的定義相同的定義。 In Chemical Formulae 2-1 to 2-6, R 11 to R 19 , A 1 , A 2 and d have the same definitions as in Chemical Formula 2.
在本申請案的一個實施例中,化學式2可由以下化學式2-7至化學式2-9中的任一者表示。 In one embodiment of the present application, Chemical Formula 2 can be represented by any one of the following Chemical Formulas 2-7 to 2-9.
[化學式2-7]
在化學式2-7至化學式2-9中,A1、A2、R11及R14具有與化學式2中的定義相同的定義,A3為O;S;或者NRg,R50及R51為氫;或者經取代或未經取代的芳基,且R50及R51中的至少一者為經取代或未經取代的芳基,Rg、R52及R53彼此相同或彼此不同,且各自獨立地為氫;經取代或未經取代的烷基;經取代或未經取代的芳基;或者經取代或 未經取代的雜芳基,r為0至3的整數,且q為0至4的整數。 In Chemical Formulae 2-7 to 2-9, A1 , A2 , R11 and R14 have the same definitions as in Chemical Formula 2, A3 is O; S; or NRg , R50 and R51 are hydrogen; or a substituted or unsubstituted aryl group, and at least one of R50 and R51 is a substituted or unsubstituted aryl group, Rg , R52 and R53 are the same as or different from each other and are each independently hydrogen; a substituted or unsubstituted alkyl group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group, r is an integer from 0 to 3, and q is an integer from 0 to 4.
在本申請案的一個實施例中,R50及R51可為氫;或者經取代或未經取代的芳基。 In one embodiment of the present application, R 50 and R 51 may be hydrogen; or a substituted or unsubstituted aryl group.
在另一實施例中,R50及R51可為氫;或者經取代或未經取代的C6至C60芳基。 In another embodiment, R 50 and R 51 may be hydrogen; or a substituted or unsubstituted C6 to C60 aryl group.
在另一實施例中,R50及R51可為氫;或者經取代或未經取代的C6至C40芳基。 In another embodiment, R 50 and R 51 may be hydrogen; or a substituted or unsubstituted C6 to C40 aryl group.
在另一實施例中,R50及R51可為氫;或者C6至C40芳基。 In another embodiment, R 50 and R 51 may be hydrogen; or C6 to C40 aryl.
在另一實施例中,R50及R51可為氫;苯基;或者三伸苯基。 In another embodiment, R 50 and R 51 can be hydrogen; phenyl; or terphenylene.
在本申請案的一個實施例中,R50及R51中的至少一者可為經取代或未經取代的芳基。 In one embodiment of the present application, at least one of R 50 and R 51 may be a substituted or unsubstituted aryl group.
在本申請案的一個實施例中,R52及R53可為氫。 In one embodiment of the present application, R 52 and R 53 may be hydrogen.
在本申請案的一個實施例中,Rg可為經取代或未經取代的芳基。 In one embodiment of the present application, Rg may be a substituted or unsubstituted aryl group.
在另一實施例中,Rg可為經取代或未經取代的C6至C60芳基。 In another embodiment, Rg may be a substituted or unsubstituted C6 to C60 aryl group.
在另一實施例中,Rg可為經取代或未經取代的C6至C40芳基。 In another embodiment, Rg may be a substituted or unsubstituted C6 to C40 aryl group.
在另一實施例中,Rg可為C6至C40芳基。 In another embodiment, Rg may be a C6 to C40 aryl group.
在另一實施例中,Rg可為苯基;或者聯苯基。 In another embodiment, Rg can be phenyl; or biphenyl.
當如在化學式2-7中一樣具有稠合型基環(fused-type base ring)時,當與化學式1所示雜環化合物一起用於有機發光裝置中時,特別是作為主體材料時,會獲得非常快速的電洞轉移性質,此會降低所述裝置的臨限電壓及驅動電壓,且因此,即使在低電壓下亦可驅動所述裝置。 When having a fused-type base ring as in Chemical Formula 2-7, when used together with the heterocyclic compound shown in Chemical Formula 1 in an organic light-emitting device, especially as a host material, a very fast hole transfer property is obtained, which reduces the critical voltage and driving voltage of the device, and thus, the device can be driven even at a low voltage.
當如在化學式2-8中一樣在稠合型環結構中具有取代基(R50)時,相較於化學式2-7而言,會獲得較大的結構,且由於所述性質,共軛區域向自基礎骨架延伸的取代基(R50)變寬,且會獲得進一步加寬形式的最高佔用分子軌道(highest occupied molecular orbital,HOMO)能級區域。因此,電洞分佈至寬的HOMO能級區域,且可維持更穩定的電洞轉移能力。換言之,在例如化學式2-8的情形中,驅動電壓會增加至一定程度,然而,會獲得更優越的總壽命性質。 When there is a substituent (R 50 ) in the condensed ring structure as in Chemical Formula 2-8, a larger structure is obtained compared to Chemical Formula 2-7, and due to the properties, the conjugated region becomes wider toward the substituent (R 50 ) extending from the basic skeleton, and a further widened highest occupied molecular orbital (HOMO) energy level region is obtained. Therefore, holes are distributed to the wide HOMO energy level region, and more stable hole transfer ability can be maintained. In other words, in the case of Chemical Formula 2-8, for example, the driving voltage is increased to a certain extent, however, a more superior overall life property is obtained.
化學式2-9是稠合型環結構被雜芳基取代的情形,且同時由於具有如在化學式2-8中一樣藉由寬共軛區維持穩定HOMO能級的性質,因此可用作藉由各種雜芳基取代來控制能帶間隙的輔助手段。具體而言,由於二苯並呋喃/二苯並噻吩基等具有在結構上最大的結構,因此驅動電壓相較於基礎骨架而言稍微增加,然而,由於除維持較高T1能級的性質之外亦具有最高結構穩定性,因此會獲得特別優越的裝置壽命性質。 Chemical formula 2-9 is a case where the fused ring structure is substituted by a heteroaryl group, and because it has the property of maintaining a stable HOMO energy level through a wide conjugated region as in chemical formula 2-8, it can be used as an auxiliary means to control the band gap through various heteroaryl substitutions. Specifically, since dibenzofuran/dibenzothiophene groups have the largest structure in structure, the driving voltage is slightly increased compared to the basic skeleton. However, in addition to maintaining the property of a higher T1 energy level, it also has the highest structural stability, so it will obtain particularly superior device life properties.
當在有機發光裝置的有機材料層中包含化學式1所示雜環化合物與化學式2所示雜環化合物二者時,會獲得更優越的效率及壽命效果。此種結果可能導致預測出:當同時包含所述兩種化合物時,會發生激發錯合體現象(exciplex phenomenon)。 When both the heterocyclic compound shown in Chemical Formula 1 and the heterocyclic compound shown in Chemical Formula 2 are included in the organic material layer of the organic light-emitting device, better efficiency and life effects are obtained. This result may lead to the prediction that when the two compounds are included at the same time, an exciplex phenomenon will occur.
激發錯合體現象是由於兩個分子之間的電子交換而釋放具有施體(p-主體)HOMO能級及受體(n-主體)最低未佔用分子軌道(lowest unoccupied molecular orbital,LUMO)能級大小的能量的現象。當兩個分子之間發生激發錯合體現象時,會發生逆向系統間交叉(reverse intersystem crossing,RISC),且因此螢光的內部量子效率可提高至達100%。當具有合意的電洞轉移能力的施體(p-主體)及具有合意的電子轉移能力的受體(n-主體)用作發光層的主體時,電洞被注入至p-主體,且電子被注入至n-主體,且因此,驅動電壓可降低,此最終有助於壽命的提高。 The excited complex phenomenon is a phenomenon in which energy having the magnitude of the donor (p-host) HOMO energy level and the acceptor (n-host) lowest unoccupied molecular orbital (LUMO) energy level is released due to electron exchange between two molecules. When the excited complex phenomenon occurs between two molecules, reverse intersystem crossing (RISC) occurs, and thus the internal quantum efficiency of fluorescence can be increased up to 100%. When a donor (p-host) having a desirable hole transfer ability and an acceptor (n-host) having a desirable electron transfer ability are used as hosts of the light-emitting layer, holes are injected into the p-host and electrons are injected into the n-host, and thus the driving voltage can be reduced, which ultimately contributes to an increase in lifetime.
根據本申請案的一個實施例,化學式1可由以下化合物中的任一種表示,但不限於此。 According to an embodiment of the present application, Chemical Formula 1 can be represented by any one of the following compounds, but is not limited thereto.
在本申請案的一個實施例中,化學式2可由以下化合物中的任一種表示,但不限於此。 In one embodiment of the present application, Chemical Formula 2 can be represented by any one of the following compounds, but is not limited thereto.
另外,藉由將各種取代基引入化學式1及化學式2所示的結構,可合成具有所引入取代基的獨特性質的化合物。舉例而言,藉由將通常用作用於製造有機發光裝置的電洞注入層材料、電洞轉移層材料、發光層材料、電子轉移層材料及電荷產生層材料的取代基引入核心結構,可合成滿足每一有機材料層所需條件的材料。 In addition, by introducing various substituents into the structures shown in Chemical Formula 1 and Chemical Formula 2, compounds having unique properties of the introduced substituents can be synthesized. For example, by introducing substituents commonly used as hole injection layer materials, hole transfer layer materials, light-emitting layer materials, electron transfer layer materials, and charge generation layer materials for manufacturing organic light-emitting devices into the core structure, materials that meet the required conditions for each organic material layer can be synthesized.
另外,藉由將各種取代基引入化學式1及化學式2所示的結構,可精細地控制能帶間隙,且同時,有機材料之間的介面處的性質增強,且材料應用可變得多樣化。 In addition, by introducing various substituents into the structures shown in Chemical Formula 1 and Chemical Formula 2, the energy band gap can be finely controlled, and at the same time, the properties at the interface between organic materials are enhanced, and the application of materials can be diversified.
同時,雜環化合物具有高玻璃轉變溫度(Tg),且具有極佳的熱穩定性。熱穩定性的此種增加成為為裝置提供驅動穩定性的重要因素。 At the same time, heterocyclic compounds have a high glass transition temperature (Tg) and have excellent thermal stability. This increase in thermal stability becomes an important factor in providing driving stability to the device.
根據本申請案的一個實施例的雜環化合物可使用多步驟化學反應來製備。首先製備一些中間化合物,且可自中間化合物 製備化學式1或化學式2所示的化合物。更具體而言,根據本申請案的一個實施例的雜環化合物可基於稍後欲闡述的製備實例來製備。 The heterocyclic compound according to one embodiment of the present application can be prepared using a multi-step chemical reaction. First, some intermediate compounds are prepared, and the compound shown in Chemical Formula 1 or Chemical Formula 2 can be prepared from the intermediate compounds. More specifically, the heterocyclic compound according to one embodiment of the present application can be prepared based on the preparation example to be described later.
另外,本申請案的另一實施例提供一種用於有機發光裝置的有機材料層的組成物,所述組成物包含由化學式1表示的雜環化合物及由化學式2表示的化合物。 In addition, another embodiment of the present application provides a composition for an organic material layer of an organic light-emitting device, wherein the composition comprises a heterocyclic compound represented by Chemical Formula 1 and a compound represented by Chemical Formula 2.
關於由化學式1表示的雜環化合物及由化學式2表示的化合物的具體細節與以上所提供的說明相同。 The specific details of the heterocyclic compound represented by Chemical Formula 1 and the compound represented by Chemical Formula 2 are the same as those provided above.
在所述組成物中,由化學式1表示的雜環化合物:由化學式2表示的化合物可具有1:10至10:1、1:8至8:1、1:5至5:1或1:2至2:1的重量比率,然而,重量比率不限於此。 In the composition, the heterocyclic compound represented by Chemical Formula 1: the compound represented by Chemical Formula 2 may have a weight ratio of 1:10 to 10:1, 1:8 to 8:1, 1:5 to 5:1, or 1:2 to 2:1, however, the weight ratio is not limited thereto.
所述組成物可在形成有機發光裝置的有機材料時使用,且具體而言,可更佳地在形成發光層的主體時使用。 The composition can be used when forming an organic material of an organic light-emitting device, and more specifically, can be used more preferably when forming the main body of a light-emitting layer.
所述組成物具有簡單混合所述化合物中的二或更多種的形式,且粉末形式的材料可在形成有機發光裝置的有機材料層之前進行混合,或者液態的化合物可在高於適當溫度的溫度下進行混合。所述組成物在所述材料中的每一者的熔點以下呈固態,且可藉由調節溫度而維持在液態。 The composition has a form of simply mixing two or more of the compounds, and the materials in powder form can be mixed before forming the organic material layer of the organic light-emitting device, or the liquid compounds can be mixed at a temperature higher than an appropriate temperature. The composition is solid below the melting point of each of the materials and can be maintained in a liquid state by adjusting the temperature.
所述組成物可更包含例如溶劑及添加劑等此項技術中已知的材料。 The composition may further include materials known in the art such as solvents and additives.
除使用上述由化學式1表示的雜環化合物及由化學式2表示的雜環化合物來形成一或多個有機材料層以外,根據本申請 案的一個實施例的有機發光裝置可使用常見的有機發光裝置製造方法及材料來製造。 In addition to using the above-mentioned heterocyclic compound represented by Chemical Formula 1 and the heterocyclic compound represented by Chemical Formula 2 to form one or more organic material layers, the organic light-emitting device according to an embodiment of the present application can be manufactured using common organic light-emitting device manufacturing methods and materials.
當製造有機發光裝置時,可藉由溶液塗佈方法以及真空沈積方法將由化學式1表示的化合物及由化學式2表示的化合物形成為有機材料層。在本文中,溶液塗佈方法意指旋塗(spin coating)、浸塗(dip coating)、噴墨印刷(inkjet printing)、絲網印刷(screen priting)、噴塗方法(spray method)、輥塗(roll coating)等,但不限於此。 When manufacturing an organic light-emitting device, the compound represented by Chemical Formula 1 and the compound represented by Chemical Formula 2 can be formed into an organic material layer by a solution coating method and a vacuum deposition method. In this article, the solution coating method means spin coating, dip coating, inkjet printing, screen printing, spray method, roll coating, etc., but is not limited thereto.
本揭露的有機發光裝置的有機材料層可形成為單層結構,或者亦可形成為其中層壓有二或更多個有機材料層的多層結構。舉例而言,根據本揭露的一個實施例的有機發光裝置可具有包括電洞注入層、電洞轉移層、發光層、電子轉移層、電子注入層等作為有機材料層的結構。然而,有機發光裝置的結構不限於此,且可包括更少數目的有機材料層。 The organic material layer of the organic light-emitting device disclosed herein may be formed into a single-layer structure, or may be formed into a multi-layer structure in which two or more organic material layers are laminated. For example, an organic light-emitting device according to an embodiment of the present disclosure may have a structure including a hole injection layer, a hole transfer layer, a light-emitting layer, an electron transfer layer, an electron injection layer, etc. as organic material layers. However, the structure of the organic light-emitting device is not limited thereto, and may include a smaller number of organic material layers.
具體而言,根據本申請案的一個實施例的有機發光裝置包括:第一電極;第二電極;以及一或多個有機材料層,設置於第一電極與第二電極之間,且所述一或多個有機材料層包含由化學式1表示的雜環化合物及由化學式2表示的雜環化合物。 Specifically, an organic light-emitting device according to an embodiment of the present application includes: a first electrode; a second electrode; and one or more organic material layers disposed between the first electrode and the second electrode, and the one or more organic material layers include a heterocyclic compound represented by Chemical Formula 1 and a heterocyclic compound represented by Chemical Formula 2.
在本申請案的一個實施例中,第一電極可為陽極,且第二電極可為陰極。 In one embodiment of the present application, the first electrode may be an anode, and the second electrode may be a cathode.
在另一實施例中,第一電極可為陰極,且第二電極可為陽極。 In another embodiment, the first electrode may be a cathode and the second electrode may be an anode.
在本申請案的一個實施例中,有機發光裝置可為藍色有機發光裝置,且根據化學式1的雜環化合物及根據化學式2的雜環化合物可用作藍色有機發光裝置的材料。 In one embodiment of the present application, the organic light-emitting device may be a blue organic light-emitting device, and the heterocyclic compound according to Chemical Formula 1 and the heterocyclic compound according to Chemical Formula 2 may be used as materials for the blue organic light-emitting device.
在本申請案的一個實施例中,有機發光裝置可為綠色有機發光裝置,且由化學式1表示的雜環化合物及由化學式2表示的雜環化合物可用作綠色有機發光裝置的材料。 In one embodiment of the present application, the organic light-emitting device may be a green organic light-emitting device, and the heterocyclic compound represented by Chemical Formula 1 and the heterocyclic compound represented by Chemical Formula 2 may be used as materials for the green organic light-emitting device.
在本申請案的一個實施例中,有機發光裝置可為紅色有機發光裝置,且由化學式1表示的雜環化合物及由化學式2表示的雜環化合物可用作紅色有機發光裝置的材料。 In one embodiment of the present application, the organic light-emitting device may be a red organic light-emitting device, and the heterocyclic compound represented by Chemical Formula 1 and the heterocyclic compound represented by Chemical Formula 2 may be used as materials for the red organic light-emitting device.
本揭露的有機發光裝置可更包括選自由發光層、電洞注入層、電洞轉移層、電子注入層、電子轉移層、電子阻擋層及電洞阻擋層組成的群組的一個、兩個或更多個層。 The organic light-emitting device disclosed herein may further include one, two or more layers selected from the group consisting of a light-emitting layer, a hole injection layer, a hole transfer layer, an electron injection layer, an electron transfer layer, an electron blocking layer and a hole blocking layer.
在本申請案的一個實施例中所提供的有機發光裝置中,有機材料層包括電洞阻擋層、電子注入層及電子轉移層中的至少一者,且電洞阻擋層、電子注入層及電子轉移層中的至少一者包含由化學式1表示的雜環化合物及由化學式2表示的雜環化合物。 In an organic light-emitting device provided in one embodiment of the present application, the organic material layer includes at least one of a hole blocking layer, an electron injection layer, and an electron transfer layer, and at least one of the hole blocking layer, the electron injection layer, and the electron transfer layer includes a heterocyclic compound represented by Chemical Formula 1 and a heterocyclic compound represented by Chemical Formula 2.
在本申請案的一個實施例中所提供的有機發光裝置中,有機材料層包括發光層,且發光層包含由化學式1表示的雜環化合物及由化學式2表示的雜環化合物。 In an organic light-emitting device provided in one embodiment of the present application, the organic material layer includes a light-emitting layer, and the light-emitting layer includes a heterocyclic compound represented by Chemical Formula 1 and a heterocyclic compound represented by Chemical Formula 2.
在本申請案的一個實施例中所提供的有機發光裝置中,有機材料層包括發光層,發光層包含主體材料,且主體材料包括由化學式1表示的雜環化合物及由化學式2表示的雜環化合物。 In an organic light-emitting device provided in one embodiment of the present application, the organic material layer includes a light-emitting layer, the light-emitting layer includes a main material, and the main material includes a heterocyclic compound represented by Chemical Formula 1 and a heterocyclic compound represented by Chemical Formula 2.
圖1至圖3示出根據本申請案的一個實施例的有機發光裝置的電極及有機材料層的層壓次序。然而,本申請案的範圍不限於該些圖,且此項技術中已知的有機發光裝置的結構亦可用於本申請案中。 Figures 1 to 3 show the lamination sequence of the electrode and the organic material layer of an organic light-emitting device according to an embodiment of the present application. However, the scope of the present application is not limited to these figures, and the structure of the organic light-emitting device known in the art can also be used in the present application.
圖1示出其中陽極200、有機材料層300及陰極400相繼地層壓於基板100上的有機發光裝置。然而,所述結構不限於此種結構,且如圖2中所示,亦可獲得其中陰極、有機材料層及陽極相繼地層壓於基板上的有機發光裝置。 FIG. 1 shows an organic light-emitting device in which an anode 200, an organic material layer 300, and a cathode 400 are successively layered on a substrate 100. However, the structure is not limited to this structure, and as shown in FIG. 2, an organic light-emitting device in which a cathode, an organic material layer, and an anode are successively layered on a substrate can also be obtained.
圖3示出有機材料層為多層的情形。根據圖3的有機發光裝置包括電洞注入層301、電洞轉移層302、發光層303、電洞阻擋層304、電子轉移層305及電子注入層306。然而,本申請案的範圍不限於此種層壓結構,且視需要,可不包括除發光層之外的其他層,且可更包括其他必要的功能層。 FIG3 shows a case where the organic material layer is multi-layered. The organic light-emitting device according to FIG3 includes a hole injection layer 301, a hole transfer layer 302, a light-emitting layer 303, a hole blocking layer 304, an electron transfer layer 305, and an electron injection layer 306. However, the scope of the present application is not limited to such a laminated structure, and may not include other layers except the light-emitting layer as needed, and may further include other necessary functional layers.
本申請案的一個實施例提供一種用於製造有機發光裝置的方法,所述方法包括:製備基板;在基板上形成第一電極;在第一電極上形成一或多個有機材料層;以及在所述有機材料層上形成第二電極,其中所述形成有機材料層包括使用根據本申請案的一個實施例的用於有機材料層的組成物形成一或多個有機材料層。 One embodiment of the present application provides a method for manufacturing an organic light-emitting device, the method comprising: preparing a substrate; forming a first electrode on the substrate; forming one or more organic material layers on the first electrode; and forming a second electrode on the organic material layer, wherein the forming of the organic material layer comprises forming one or more organic material layers using a composition for an organic material layer according to one embodiment of the present application.
在本申請案的一個實施例中所提供的用於製造有機發光裝置的方法中,所述形成有機材料層是在預混合化學式1所示的雜環化合物與化學式2所示的雜環化合物之後使用熱真空沈積 方法來形成。 In a method for manufacturing an organic light-emitting device provided in one embodiment of the present application, the organic material layer is formed by premixing the heterocyclic compound shown in Chemical Formula 1 and the heterocyclic compound shown in Chemical Formula 2 using a thermal vacuum deposition method.
預混合意指在沈積於有機材料層上之前,在一個供應源中預先混合由化學式1所示的雜環化合物構成的材料與由化學式2所示的雜環化合物構成的材料。由於使用了一個供應源,而不是使用2至3個供應源,因此預混合具有使製程更簡單的優點。 Premixing means that the material composed of the heterocyclic compound represented by Chemical Formula 1 and the material composed of the heterocyclic compound represented by Chemical Formula 2 are premixed in one supply source before being deposited on the organic material layer. Premixing has the advantage of making the process simpler because one supply source is used instead of 2 to 3 supply sources.
根據本申請案的一個實施例,預混合材料可被稱為用於有機材料層的組成物。 According to one embodiment of the present application, the premixed material may be referred to as a composition for an organic material layer.
當如上所述進行預混合時,需要在混合中辨識每一種材料的獨特熱性質。在本文中,當自一個供應源沈積預混合主體材料時,材料的獨特熱性質可顯著影響包括沈積速率在內的沈積條件。當二或更多種類型的預混合材料之間的熱性質不相似且非常不同時,在沈積製程中可能無法維持可重複性(repeatability)及再現性(reproducibility),此意指不可能在一個沈積製程中製造出完全均勻的有機發光二極體(organic light emitting diode,OLED)。 When premixing as described above, the unique thermal properties of each material in the mix need to be identified. In this context, when premixed host materials are deposited from one supply source, the unique thermal properties of the materials can significantly affect deposition conditions, including deposition rate. When the thermal properties between two or more types of premixed materials are dissimilar and very different, repeatability and reproducibility may not be maintained in the deposition process, which means that it is impossible to produce a completely uniform organic light emitting diode (OLED) in one deposition process.
鑑於以上情況,亦可依據分子結構的形狀來控制材料的熱性質,同時使用材料中的每一者的基礎結構與取代基的適當組合來調協材料的電性質。因此,除基礎結構之外,亦可使用化學式2中的各種取代基以及化學式2中的稠合咔唑的C-N鍵合來增強裝置效能,且可藉由控制材料中的每一者的熱性質來確保主體-主體之間的各種預混合沈積製程的多樣性。此具有確保使用三種、四種或更多種主體材料以及兩種化合物作為主體的預混合沈積製程的多樣性的優點。 In view of the above, the thermal properties of the material can also be controlled according to the shape of the molecular structure, while the electrical properties of the material can be adjusted using the appropriate combination of the basic structure and substituents of each of the materials. Therefore, in addition to the basic structure, various substituents in Chemical Formula 2 and the C-N bond of the fused carbazole in Chemical Formula 2 can also be used to enhance device performance, and the diversity of various pre-mixed deposition processes between hosts can be ensured by controlling the thermal properties of each of the materials. This has the advantage of ensuring the diversity of pre-mixed deposition processes using three, four or more host materials and two compounds as hosts.
在根據本申請案的一個實施例的有機發光裝置中,下文示出除化學式1所示的雜環化合物及化學式2所示的雜環化合物之外的材料,然而,該些僅是出於例示目的,而不是為了限制本申請案的範圍,且可由此項技術中已知的材料替換。 In an organic light-emitting device according to an embodiment of the present application, materials other than the heterocyclic compound shown in Chemical Formula 1 and the heterocyclic compound shown in Chemical Formula 2 are shown below, however, these are only for illustrative purposes and are not intended to limit the scope of the present application and can be replaced by materials known in the art.
作為陽極材料,可使用具有相對大的功函數的材料,且可使用透明導電氧化物、金屬、導電聚合物等。陽極材料的具體實例包括金屬,例如釩、鉻、銅、鋅及金或者其合金;金屬氧化物,例如氧化鋅、氧化銦、氧化銦錫(indium tin oxide,ITO)及氧化銦鋅(indium zinc oxide,IZO);金屬與氧化物的組合,例如ZnO:Al或SnO2:Sb;導電聚合物,例如聚(3-甲基噻吩)、聚[3,4-(乙烯-1,2-二氧基)噻吩](poly[3,4-(ethylene-1,2-dioxy)thiophene],PEDOT)、聚吡咯及聚苯胺;以及類似物,但不限於此。 As the anode material, a material having a relatively large work function may be used, and transparent conductive oxides, metals, conductive polymers, etc. may be used. Specific examples of the anode material include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO:Al or SnO 2 :Sb; conductive polymers such as poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDOT), polypyrrole, and polyaniline; and the like, but are not limited thereto.
作為陰極材料,可使用具有相對小的功函數的材料,且可使用金屬、金屬氧化物、導電聚合物等。陰極材料的具體實例包括金屬,例如鎂、鈣、鈉、鉀、鈦、銦、釔、鋰、釓、鋁、銀、錫及鉛,或其合金;多層結構材料,例如LiF/Al或LiO2/Al;以及類似物,但不限於此。 As the cathode material, a material having a relatively small work function may be used, and metals, metal oxides, conductive polymers, etc. may be used. Specific examples of the cathode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, and lead, or alloys thereof; multilayer structure materials such as LiF/Al or LiO2 /Al; and the like, but are not limited thereto.
作為電洞注入材料,可使用已知的電洞注入材料,且舉例而言,可使用酞菁化合物,例如在美國專利第4,356,429號中揭露的銅酞菁;或者星爆型胺衍生物,例如在文獻[先進材料(Advanced Material),6,p.677(1994)]中闡述的三(4-咔唑基-9-基苯基)胺(tris(4-carbazoyl-9-ylphenyl)amine,TCTA)、4,4',4"-三[苯 基(間甲苯基)胺基]三苯基胺(4,4',4"-tri[phenyl(m-tolyl)amino]triphenylamine,m-MTDATA)或1,3,5-三[4-(3-甲基苯基苯基胺基)苯基]苯(1,3,5-tris[4-(3-methylphenylphenylamino)phenyl]benzene,m-MTDAPB);作為具有溶解性的導電聚合物的聚苯胺/十二基苯磺酸、聚(3,4-乙烯二氧基噻吩)/聚(4-苯乙烯磺酸鹽)、聚苯胺/樟腦磺酸或聚苯胺/聚(4-苯乙烯-磺酸鹽);以及類似物。 As the hole injection material, a known hole injection material can be used, and for example, a phthalocyanine compound, such as copper phthalocyanine disclosed in U.S. Patent No. 4,356,429, or a starburst amine derivative, such as that disclosed in the literature [Advanced Materials], can be used. =Tris(4-carbazoyl-9-ylphenyl)amine (TCTA), 4,4',4"-tri[phenyl(m-tolyl)amino]triphenylamine (m-MTDATA) or 1,3,5-tris[4-(3-methylphenylphenylamino)phenyl]benzene (m-MTDAPB) as described in [Material], 6, p.677 (1994); polyaniline/dodecylbenzenesulfonic acid, poly(3,4-ethylenedioxythiophene)/poly(4-styrenesulfonate), polyaniline/camphorsulfonic acid or polyaniline/poly(4-styrene-sulfonate) as soluble conductive polymers; and the like.
作為電洞轉移材料,可使用吡唑啉衍生物、芳基胺系衍生物、二苯乙烯衍生物、三苯基二胺衍生物等,且亦可使用低分子或高分子材料。 As hole transfer materials, pyrazoline derivatives, arylamine derivatives, diphenylethylene derivatives, triphenyldiamine derivatives, etc. can be used, and low molecular weight or high molecular weight materials can also be used.
作為電子轉移材料,可使用噁二唑衍生物、蒽醌二甲烷及其衍生物、苯醌及其衍生物、萘醌及其衍生物、蒽醌及其衍生物、四氰基蒽醌二甲烷及其衍生物、芴酮衍生物、二苯基二氰基乙烯及其衍生物、聯苯醌衍生物、8-羥基喹啉及其衍生物等的金屬錯合物,且亦可使用高分子材料以及低分子材料。 As electron transfer materials, metal complexes such as oxadiazole derivatives, anthraquinone dimethane and its derivatives, benzoquinone and its derivatives, naphthoquinone and its derivatives, anthraquinone and its derivatives, tetracyanoanthraquinone dimethane and its derivatives, fluorenone derivatives, diphenyl dicyanoethylene and its derivatives, diphenoquinone derivatives, 8-hydroxyquinoline and its derivatives can be used, and polymer materials and low molecular weight materials can also be used.
作為電子注入材料的實例,此項技術中通常使用LiF,然而,本申請案不限於此。 As an example of an electron injection material, LiF is generally used in this technology, however, the present application is not limited thereto.
作為發光材料,可使用紅色、綠色或藍色發光材料,且視需要,可混合及使用二或更多種發光材料。在本文中,二或更多種發光材料可藉由沈積作為各別的供應源或者藉由預混合並沈積作為一個供應源來使用。另外,螢光材料亦可用作發光材料,然而,亦可使用磷光材料。作為發光材料,可單獨使用藉由鍵合分別自陽 極及陰極注入的電子及電洞來發光的材料,然而,亦可使用具有一起涉及發光的主體材料與摻雜劑材料的材料。 As the luminescent material, a red, green or blue luminescent material can be used, and two or more luminescent materials can be mixed and used as needed. In this article, two or more luminescent materials can be used by deposition as individual supply sources or by pre-mixing and deposition as one supply source. In addition, a fluorescent material can also be used as a luminescent material, however, a phosphorescent material can also be used. As the luminescent material, a material that emits light by bonding electrons and holes injected from the anode and the cathode, respectively, can be used alone, however, a material having a host material and a dopant material that together involve light emission can also be used.
當混合發光材料主體時,相同系列的主體可進行混合,或者不同系列的主體可進行混合。舉例而言,可選擇n型主體材料或p型主體材料中的任意二或更多種類型的材料,且將所述材料用作發光層的主體材料。 When mixing the host of light-emitting materials, hosts of the same series may be mixed, or hosts of different series may be mixed. For example, any two or more types of materials of n-type host materials or p-type host materials may be selected and used as host materials of the light-emitting layer.
視所使用的材料而定,根據本申請案的一個實施例的有機發光裝置可為頂部發射型(top-emission type)、底部發射型(bottom-emission type)或雙重發射型(dual-emission type)。 Depending on the materials used, the organic light-emitting device according to one embodiment of the present application may be a top-emission type, a bottom-emission type, or a dual-emission type.
基於與在有機發光裝置中使用的原理相似的原理,根據本申請案的一個實施例的雜環化合物亦可用於包括有機太陽能電池、有機光導體、有機電晶體等的有機電子裝置中。 Based on principles similar to those used in organic light-emitting devices, the heterocyclic compound according to one embodiment of the present application can also be used in organic electronic devices including organic solar cells, organic photoconductors, organic crystals, etc.
在下文中,將參照實例更詳細地闡述本說明書,然而,該些實例僅是出於例示目的,且本申請案的範圍不限於此。 Hereinafter, this specification will be described in more detail with reference to examples, however, these examples are for illustrative purposes only and the scope of this application is not limited thereto.
[製備實例1]化合物1(C)的製備[Preparation Example 1] Preparation of Compound 1 (C)
化合物1-1的製備Preparation of compound 1-1
在單頸圓底燒瓶(round bottom flask,r.b.f)中,將1-溴-2,3-二氟苯(40.5克,209毫莫耳)、(2-氯-6-甲氧基苯基)硼酸(43克,230毫莫耳)、四(三苯基膦)鈀(0)(24克,20.9毫莫耳)、碳酸鉀(57.9克,419毫莫耳)及甲苯/乙醇/水(500毫升/100毫升/100毫升)的混合物在110℃下進行了迴流。用二氯甲烷(dichloromethane,DCM)對所得物進行了萃取且用MgSO4進行了乾燥。對所得物進行了矽膠過濾且接著進行了濃縮以獲得化合物1-1(40.8克,76%)。 In a round bottom flask (RBF), a mixture of 1-bromo-2,3-difluorobenzene (40.5 g, 209 mmol), (2-chloro-6-methoxyphenyl)boric acid (43 g, 230 mmol), tetrakis(triphenylphosphine)palladium(0) (24 g, 20.9 mmol), potassium carbonate (57.9 g, 419 mmol) and toluene/ethanol/water (500 ml/100 ml/100 ml) was refluxed at 110°C. The resultant was extracted with dichloromethane (DCM) and dried over MgSO 4. The resultant was filtered through silica gel and then concentrated to obtain compound 1-1 (40.8 g, 76%).
化合物1-2的製備Preparation of compound 1-2
在單頸圓底燒瓶(r.b.f)中,將2'-氯-2,3-二氟-6'-甲氧基-1,1'-聯苯(40.8克,160毫莫耳)與二氯甲烷(methylene chloride,MC)(600毫升)的混合物冷卻至0℃,向其滴加BBr3(30毫升,320毫莫耳),且在將溫度升至室溫之後,將所得物攪拌了1小時。用蒸餾水終止反應,且用二氯甲烷對所得物進行萃取且用MgSO4進行了乾燥。對所得物進行了柱純化(MC:Hex=1:1),以獲得化合物1-2(21克,54%)。 In a single-necked round-bottom flask (rbf), a mixture of 2'-chloro-2,3-difluoro-6'-methoxy-1,1'-biphenyl (40.8 g, 160 mmol) and methylene chloride (MC) (600 ml) was cooled to 0°C, BBr 3 (30 ml, 320 mmol) was added dropwise thereto, and after the temperature was raised to room temperature, the resultant was stirred for 1 hour. The reaction was terminated with distilled water, and the resultant was extracted with methylene chloride and dried with MgSO 4. The resultant was column purified (MC: Hex = 1: 1) to obtain compound 1-2 (21 g, 54%).
化合物1-3的製備Preparation of Compound 1-3
在單頸圓底燒瓶(r.b.f)中,將4-氯-2',3'-二氟-[1,1'-聯苯基]-2-醇(21克,87.2毫莫耳)與Cs2CO3(71克,218毫莫耳)的二甲基乙醯胺(200毫升)混合物在120℃下進行了攪拌。將所得物冷卻且接著進行了過濾,且在移除濾液的溶劑之後,進行了柱純化(Hex:MC=4:1),以獲得化合物1-3(17克,88%)。 In a single-necked round-bottom flask (rbf), a mixture of 4-chloro-2',3'-difluoro-[1,1'-biphenyl]-2-ol (21 g, 87.2 mmol) and Cs 2 CO 3 (71 g, 218 mmol) in dimethylacetamide (200 ml) was stirred at 120° C. The resultant was cooled and then filtered, and after removing the solvent of the filtrate, column purification (Hex:MC=4:1) was performed to obtain compound 1-3 (17 g, 88%).
化合物1-4的製備Preparation of Compounds 1-4
在單頸圓底燒瓶(r.b.f)中,將1-氯-6-氟二苯並[b,d]呋喃(6克,27.19毫莫耳)、9H-咔唑(5克,29.9毫莫耳)及Cs2CO3(22克,101.7毫莫耳)的二甲基乙醯胺(60毫升)混合物在170℃下迴流了12小時。將所得物冷卻且接著進行了過濾,且在移除濾液的溶劑之後,進行了柱純化(Hex:MC=3:1),以獲得化合物1-4(9克,90%)。 In a single-necked round-bottom flask (rbf), a mixture of 1-chloro-6-fluorodibenzo[b,d]furan (6 g, 27.19 mmol), 9H-carbazole (5 g, 29.9 mmol) and Cs 2 CO 3 (22 g, 101.7 mmol) in dimethylacetamide (60 ml) was refluxed at 170° C. for 12 hours. The resultant was cooled and then filtered, and after removing the solvent of the filtrate, column purification (Hex:MC=3:1) was performed to obtain compound 1-4 (9 g, 90%).
化合物1-5的製備Preparation of Compounds 1-5
在單頸圓底燒瓶(r.b.f)中,將9-(9-氯二苯並[b,d]呋喃-4-基)-9H-咔唑(9克,24.4毫莫耳)、雙(頻哪醇基)二硼(12.4克,48.9毫莫耳)、Pcy3(1.37克,4.89毫莫耳)、乙酸鉀(7.1克,73毫莫耳)及Pd2(dba)3(2.2克,2.44毫莫耳)的1,4-二噁烷(100毫升)混合物在140℃下進行了迴流。將所得物冷卻,且對過濾濾液進行了濃縮及柱純化(Hex:MC=3:1),以獲得化合物1-5(7.2克,64%)。 In a single-necked round-bottom flask (rbf), a mixture of 9-(9-chlorodibenzo[b,d]furan-4-yl)-9H-carbazole (9 g, 24.4 mmol), bis(pinacolato)diboron (12.4 g, 48.9 mmol), Pcy 3 (1.37 g, 4.89 mmol), potassium acetate (7.1 g, 73 mmol) and Pd 2 (dba) 3 (2.2 g, 2.44 mmol) in 1,4-dioxane (100 ml) was refluxed at 140° C. The resultant was cooled, and the filtrate was concentrated and column purified (Hex:MC=3:1) to obtain compound 1-5 (7.2 g, 64%).
化合物1的製備Preparation of compound 1
在單頸圓底燒瓶(r.b.f)中,將9-(9-(4,4,5,5-四甲基-1,3,2-二氧雜戊硼烷-2-基)二苯並[b,d]呋喃-4-基)-9H-咔唑(7.2克,15.6毫莫耳)、2-氯-4,6-二苯基-1,3,5-三嗪(5克,18.8毫莫耳)、四(三苯基膦)鈀(0)(1.8克,1.56毫莫耳)、碳酸鉀(4.3克,31.2毫莫耳)及1,4-二噁烷/水(100毫升/25毫升)的混合物在120℃下迴流了4小時。將所得物在120℃下進行了過濾,且接著用1,4二噁 烷、蒸餾水及MeOH進行了洗滌,以獲得化合物1(C)(6.6克,75%)。 In a single neck round bottom flask (r.b.f), a mixture of 9-(9-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzo[b,d]furan-4-yl)-9H-carbazole (7.2 g, 15.6 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (5 g, 18.8 mmol), tetrakis(triphenylphosphine)palladium(0) (1.8 g, 1.56 mmol), potassium carbonate (4.3 g, 31.2 mmol) and 1,4-dioxane/water (100 ml/25 ml) was refluxed at 120°C for 4 hours. The resultant was filtered at 120°C and then washed with 1,4-dioxane, distilled water and MeOH to obtain Compound 1(C) (6.6 g, 75%).
除使用以下[表1]至[表7]所示的A及B作為中間體之外,以與製備實例1中化合物1的製備相同的方式合成了以下化合物C。 The following compound C was synthesized in the same manner as compound 1 in Preparation Example 1, except that A and B shown in the following [Table 1] to [Table 7] were used as intermediates.
[製備實例2]化合物129(F)的製備[Preparation Example 2] Preparation of Compound 129(F)
化合物129-1的製備Preparation of compound 129-1
在單頸圓底燒瓶(r.b.f)中,將1-溴-2,4-二氟苯(40克,207毫莫耳)、(2-氯-6-甲氧基苯基)硼酸(42.4克,227毫莫耳)、四(三苯基膦)鈀(0)(23克,20.7毫莫耳)、碳酸鉀(57克,414毫莫耳)及甲苯/乙醇/水(600毫升/150毫升/150毫升)的混合物在110℃下進行了迴流。 In a single-necked round-bottom flask (r.b.f), a mixture of 1-bromo-2,4-difluorobenzene (40 g, 207 mmol), (2-chloro-6-methoxyphenyl)boric acid (42.4 g, 227 mmol), tetrakis(triphenylphosphine)palladium(0) (23 g, 20.7 mmol), potassium carbonate (57 g, 414 mmol) and toluene/ethanol/water (600 ml/150 ml/150 ml) was refluxed at 110°C.
用二氯甲烷對所得物進行了萃取,用MgSO4進行了乾燥,進行了矽膠過濾且接著進行了濃縮,以獲得化合物129-1(50克,94%)。 The resultant was extracted with dichloromethane, dried over MgSO 4 , filtered through silica gel and then concentrated to obtain compound 129-1 (50 g, 94%).
化合物129-2的製備Preparation of compound 129-2
在單頸圓底燒瓶(r.b.f)中,將2'-氯-2,4-二氟-6'-甲氧基-1,1'-聯苯(50克,196毫莫耳)及二氯甲烷(700毫升)的混合物冷卻至0℃,向其滴加BBr3(28.3毫升,294毫莫耳),且在將溫 度升至室溫之後,將所得物攪拌了2小時。 In a single-necked round-bottom flask (rbf), a mixture of 2'-chloro-2,4-difluoro-6'-methoxy-1,1'-biphenyl (50 g, 196 mmol) and dichloromethane (700 mL) was cooled to 0°C, BBr 3 (28.3 mL, 294 mmol) was added dropwise thereto, and after the temperature was raised to room temperature, the resultant was stirred for 2 hours.
用蒸餾水終止反應,且用二氯甲烷對所得物進行了萃取且用MgSO4進行了乾燥。對所得物進行了矽膠過濾,以獲得化合物129-2(27.5克,58%)。 The reaction was terminated with distilled water, and the resultant was extracted with dichloromethane and dried over MgSO 4. The resultant was filtered through silica gel to obtain compound 129-2 (27.5 g, 58%).
化合物129-3的製備Preparation of compound 129-3
在單頸圓底燒瓶(r.b.f)中,將4-氯-2',4'-二氟-[1,1'-聯苯基]-2-醇(27克,114毫莫耳)及Cs2CO3(83克,285毫莫耳)的二甲基乙醯胺(300毫升)混合物在120℃下進行了攪拌。對所得物進行了冷卻且接著進行了過濾,且在移除濾液的溶劑之後,進行了矽膠過濾,以獲得化合物129-3(23克,92%)。 In a single-necked round-bottom flask (rbf), a mixture of 4-chloro-2',4'-difluoro-[1,1'-biphenyl]-2-ol (27 g, 114 mmol) and Cs 2 CO 3 (83 g, 285 mmol) in dimethylacetamide (300 ml) was stirred at 120° C. The resultant was cooled and then filtered, and after removing the solvent of the filtrate, silica gel filtration was performed to obtain compound 129-3 (23 g, 92%).
化合物129-4的製備Preparation of compound 129-4
在單頸圓底燒瓶(r.b.f)中,將1-氯-7-氟二苯並[b,d]呋喃(5.5克,24.9毫莫耳)、9H-咔唑(4.58克,27.4毫莫耳)及Cs2CO3(20克,62毫莫耳)的二甲基乙醯胺(60毫升)混合物在170℃下迴流了6小時。對所得物進行了冷卻且接著進行了過濾,且在移除濾液的溶劑之後,進行了柱純化(HX:MC=3:1),以獲得化合物129-4(7.6克,83%)。 In a single-necked round-bottom flask (rbf), a mixture of 1-chloro-7-fluorodibenzo[b,d]furan (5.5 g, 24.9 mmol), 9H-carbazole (4.58 g, 27.4 mmol) and Cs 2 CO 3 (20 g, 62 mmol) in dimethylacetamide (60 ml) was refluxed at 170° C. for 6 hours. The resultant was cooled and then filtered, and after removing the solvent of the filtrate, column purification (HX:MC=3:1) was performed to obtain compound 129-4 (7.6 g, 83%).
化合物129-5的製備Preparation of compound 129-5
在單頸圓底燒瓶(r.b.f)中,將9-(9-氯二苯並[b,d]呋喃-3-基)-9H-咔唑(7.5克,20.3毫莫耳)、雙(頻哪醇基)二硼(10.3克,40.7毫莫耳)、Pcy3(1.14克,4.07毫莫耳)、乙酸鉀(5.97克,60.9毫莫耳)及Pd2(dba)3(1.85克,2.03毫莫耳)的1,4-二噁烷 (80毫升)混合物在140℃下進行了迴流。將所得物冷卻,且對過濾濾液進行了濃縮及柱純化(HX:MC=2:1),以獲得化合物129-5(6.5克,70%)。 In a single-necked round-bottom flask (rbf), a mixture of 9-(9-chlorodibenzo[b,d]furan-3-yl)-9H-carbazole (7.5 g, 20.3 mmol), bis(pinacolato)diboron (10.3 g, 40.7 mmol), Pcy 3 (1.14 g, 4.07 mmol), potassium acetate (5.97 g, 60.9 mmol) and Pd 2 (dba) 3 (1.85 g, 2.03 mmol) in 1,4-dioxane (80 ml) was refluxed at 140° C. The resultant was cooled, and the filtrate was concentrated and column purified (HX:MC=2:1) to obtain compound 129-5 (6.5 g, 70%).
化合物129的製備Preparation of compound 129
在單頸圓底燒瓶(r.b.f)中,將9-(9-(4,4,5,5-四甲基-1,3,2-二氧雜戊硼烷-2-基)二苯並[b,d]呋喃-3-基)-9H-咔唑(6.5克,14.1毫莫耳)、2-氯-4,6-二苯基-1,3,5-三嗪(4.54克,16.9毫莫耳)、四(三苯基膦)鈀(0)(1.6克,1.41毫莫耳)、碳酸鉀(3.9克,28.2毫莫耳)及1,4-二噁烷/水(80毫升/28.2毫升)的混合物在120℃下迴流了4小時。在60℃下對所得物進行了過濾,且接著用60℃的1,4-二噁烷、蒸餾水及MeOH進行了洗滌,以獲得化合物129(F)(5.4克,68%)。 In a single neck round bottom flask (r.b.f), a mixture of 9-(9-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzo[b,d]furan-3-yl)-9H-carbazole (6.5 g, 14.1 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (4.54 g, 16.9 mmol), tetrakis(triphenylphosphine)palladium(0) (1.6 g, 1.41 mmol), potassium carbonate (3.9 g, 28.2 mmol) and 1,4-dioxane/water (80 ml/28.2 ml) was refluxed at 120°C for 4 hours. The resultant was filtered at 60°C, and then washed with 60°C 1,4-dioxane, distilled water and MeOH to obtain Compound 129(F) (5.4 g, 68%).
除使用以下[表8]至[表14]所示的D及E作為中間體之外,以與製備實例2中化合物129的製備相同的方式合成了以下化合物F。 The following compound F was synthesized in the same manner as the preparation of compound 129 in Preparation Example 2, except that D and E shown in the following [Table 8] to [Table 14] were used as intermediates.
[表10]
除表1至14中所述的化合物之外,亦以與以上所提供的製備實例中所述的方法相同的方式製備了化合物1至286。 In addition to the compounds described in Tables 1 to 14, compounds 1 to 286 were also prepared in the same manner as described in the preparation examples provided above.
<製備實例3>化合物2-6的合成<Preparation Example 3> Synthesis of Compound 2-6
1)化合物2-6的製備1) Preparation of Compound 2-6
在將5-苯基-5,7-二氫吲哚並[2,3-b]咔唑(6.0克,18.05毫莫耳/升(mM))、4-溴-1,1';4',1"-三聯苯(6.7克,21.66毫莫耳/升)、Pd2(dba)3(0.824克,0.90毫莫耳/升)、Sphos(0.74克,1.80毫莫耳/升)及t-BuONa(3.47克,36.10毫莫耳/升)溶解於1,4-二噁烷(1,4-dioxane)(60毫升)中之後,將所得物迴流了24小時。在反應完成之後,藉由在室溫下向其引入蒸餾水及二氯甲烷(DCM)對所得物進行了萃取,且在用MgSO4對有機層進行乾燥之後,使 用旋轉蒸發器移除了溶劑。將反應材料溶解於二氯苯甲醯氯(dichlorobenzoyl chloride,DCB)(100毫升)中,使用矽膠進行過濾以進行純化,且用甲醇重新結晶,以獲得目標化合物2-6(8.6克,85%)。 After dissolving 5-phenyl-5,7-dihydroindolo[2,3-b]carbazole (6.0 g, 18.05 mmol/L (mM)), 4-bromo-1,1';4',1"-terphenyl (6.7 g, 21.66 mmol/L), Pd2 (dba) 3 (0.824 g, 0.90 mmol/L), Sphos (0.74 g, 1.80 mmol/L) and t-BuONa (3.47 g, 36.10 mmol/L) in 1,4-dioxane (60 mL), the resultant was refluxed for 24 hours. After completion of the reaction, the resultant was extracted by introducing distilled water and dichloromethane (DCM) thereto at room temperature, and then the mixture was washed with MgSO4. 4 After the organic layer was dried, the solvent was removed using a rotary evaporator. The reaction material was dissolved in dichlorobenzoyl chloride (DCB) (100 mL), purified by filtration using silica gel, and recrystallized from methanol to obtain the target compound 2-6 (8.6 g, 85%).
除使用下表15所示的中間體A-1代替4-溴-1,1';4',1"-三聯苯且使用下表15所示的中間體B-1代替5-苯基-5,7-二氫吲哚並[2,3-b]咔唑之外,以與製備實例3相同的方式合成了目標化合物A。 The target compound A was synthesized in the same manner as in Preparation Example 3, except that the intermediate A-1 shown in Table 15 below was used instead of 4-bromo-1,1';4',1"-terphenyl and the intermediate B-1 shown in Table 15 below was used instead of 5-phenyl-5,7-dihydroindole[2,3-b]carbazole.
<製備實例4>化合物2-79的合成<Preparation Example 4> Synthesis of Compound 2-79
1)化合物2-79-2的製備1) Preparation of compound 2-79-2
在將2-氯-7-苯基-5,7-二氫吲哚並[2,3-b]咔唑(7.0克, 19.08毫莫耳/升)、碘苯(4.28克,20.99毫莫耳/升)、Pd2(dba)3(0.873克,0.95毫莫耳/升)、(t-Bu)3P(0.58克,2.86毫莫耳/升)、t-BuONa(3.67克,38.16毫莫耳/升)溶解於甲苯(70毫升)中之後,將所得物迴流了4小時。在反應完成之後,藉由在室溫下向其引入蒸餾水及DCM對所得物進行了萃取,且在用MgSO4對有機層進行乾燥之後,使用旋轉蒸發器移除了溶劑。對反應材料進行了柱純化(MC/Hex),且接著使用旋轉蒸發器移除了溶劑,以獲得目標化合物2-79-2(6.93克,82%)。 After dissolving 2-chloro-7-phenyl-5,7-dihydroindolo[2,3-b]carbazole (7.0 g, 19.08 mmol/L), iodobenzene (4.28 g, 20.99 mmol/L), Pd 2 (dba) 3 (0.873 g, 0.95 mmol/L), (t-Bu) 3 P (0.58 g, 2.86 mmol/L), t-BuONa (3.67 g, 38.16 mmol/L) in toluene (70 mL), the resultant was refluxed for 4 hours. After the reaction was completed, the resultant was extracted by introducing distilled water and DCM thereto at room temperature, and after the organic layer was dried over MgSO 4 , the solvent was removed using a rotary evaporator. The reaction material was column purified (MC/Hex), and then the solvent was removed using a rotary evaporator to obtain the target compound 2-79-2 (6.93 g, 82%).
除使用下表16所示的中間體C-3代替2-氯-7-苯基-5,7-二氫吲哚並[2,3-b]咔唑之外,以與製備實例4中化合物2-79-2的製備相同的方式合成了目標化合物C-2。 The target compound C-2 was synthesized in the same manner as the preparation of compound 2-79-2 in Preparation Example 4, except that the intermediate C-3 shown in Table 16 below was used instead of 2-chloro-7-phenyl-5,7-dihydroindolo[2,3-b]carbazole.
2)化合物2-79-1的製備2) Preparation of compound 2-79-1
在將2-氯-5,7-二苯基-5,7-二氫吲哚並[2,3-b]咔唑(6.93克,15.65毫莫耳/升)、雙頻哪醇基二硼烷(5.96克,23.47毫莫耳/升)、Pd2(dba)3(1.43克,1.56毫莫耳/升)、XPhos(1.49克,3.13毫莫耳/升)及KOAc(4.61克,46.94毫莫耳/升)溶解於1,4-二噁烷(70毫升)中之後,將所得物迴流了5小時。在反應完成之後,藉由在室溫下向其引入蒸餾水及DCM對所得物進行了萃取,且在用MgSO4對有機層進行乾燥之後,使用旋轉蒸發器移除了溶劑。對反應材料進行了柱純化(MC/HEX),且對濾液進行了真空濃縮,以獲得目標化合物2-79-1(6.8克,81%)。 After dissolving 2-chloro-5,7-diphenyl-5,7-dihydroindolo[2,3-b]carbazole (6.93 g, 15.65 mmol/L), bispinacolatodiborane (5.96 g, 23.47 mmol/L), Pd 2 (dba) 3 (1.43 g, 1.56 mmol/L), XPhos (1.49 g, 3.13 mmol/L) and KOAc (4.61 g, 46.94 mmol/L) in 1,4-dioxane (70 mL), the resultant was refluxed for 5 hours. After the reaction was completed, the resultant was extracted by introducing distilled water and DCM thereto at room temperature, and after the organic layer was dried over MgSO 4 , the solvent was removed using a rotary evaporator. The reaction material was column purified (MC/HEX), and the filtrate was concentrated under vacuum to obtain the target compound 2-79-1 (6.8 g, 81%).
除使用下表17所示的中間體C-2代替2-氯-5,7-二苯基-5,7-二氫吲哚並[2,3-b]咔唑之外,以與製備實例4中化合物2-79-1的製備相同的方式合成了目標化合物C-1。 The target compound C-1 was synthesized in the same manner as the preparation of compound 2-79-1 in Preparation Example 4, except that the intermediate C-2 shown in Table 17 below was used instead of 2-chloro-5,7-diphenyl-5,7-dihydroindolo[2,3-b]carbazole.
3)化合物2-79的製備3) Preparation of Compound 2-79
在將5,7-二苯基-2-(4,4,5,5-四甲基-1,3,2-二氧雜戊硼烷基)-5,7-二氫吲哚並[2,3-b]咔唑(6.8克,12.72毫莫耳/升)、3-溴-9-苯基咔唑(4.51克,14.00毫莫耳/升)、Pd(PPh3)4(0.74克,0.64毫莫耳/升)及K2CO3(3.52克,25.45毫莫耳/升)溶解於甲苯(70毫升)/乙醇(15毫升)/水(15毫升)中之後,將所得物迴流了4小時。在反應完成之後,藉由在室溫下向其引入蒸餾水及DCM對所得物進行了萃取,且在用MgSO4對有機層進行乾燥之後,使用旋轉蒸發器移除了溶劑。對反應材料進行了柱純化(MC/HEX),且對濾液進行了真空濃縮,以獲得目標化合物2-79(6.61克,80%)。 After dissolving 5,7-diphenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)-5,7-dihydroindolo[2,3-b]carbazole (6.8 g, 12.72 mmol/L), 3-bromo-9-phenylcarbazole (4.51 g, 14.00 mmol/L), Pd(PPh 3 ) 4 (0.74 g, 0.64 mmol/L) and K 2 CO 3 (3.52 g, 25.45 mmol/L) in toluene (70 mL)/ethanol (15 mL)/water (15 mL), the resultant was refluxed for 4 hours. After the reaction was completed, the resultant was extracted by introducing distilled water and DCM thereto at room temperature, and after the organic layer was dried over MgSO 4 , the solvent was removed using a rotary evaporator. The reaction material was column purified (MC/HEX), and the filtrate was vacuum concentrated to obtain the target compound 2-79 (6.61 g, 80%).
除使用下表18所示的中間體C-1代替5,7-二苯基-2-(4,4,5,5-四甲基-1,3,2-二氧雜戊硼烷基)-5,7-二氫吲哚並[2,3-b]咔唑且使用中間體D-1代替3-溴-9-苯基咔唑之外,以與製備實例4中化合物2-79的製備相同的方式合成了目標化合物C。 The target compound C was synthesized in the same manner as the preparation of compound 2-79 in Preparation Example 4, except that the intermediate C-1 shown in Table 18 below was used instead of 5,7-diphenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)-5,7-dihydroindole[2,3-b]carbazole and the intermediate D-1 was used instead of 3-bromo-9-phenylcarbazole.
除製備實例之外,亦以相同的方式製備了化學式1所示的化合物及化學式2所示的化合物。以上製備的化合物的合成辨識資料如以下[表19]及[表20]中所述。 In addition to the preparation examples, the compound represented by Chemical Formula 1 and the compound represented by Chemical Formula 2 were also prepared in the same manner. The synthetic identification data of the compounds prepared above are described in the following [Table 19] and [Table 20].
<實驗例1>有機發光裝置的製造<Experimental Example 1> Fabrication of an organic light-emitting device
用蒸餾水超聲波對上面塗佈厚度為1,500埃(Å)的氧化銦錫(ITO)來作為薄膜的玻璃基板進行了清潔。在用蒸餾水進行的清潔完成之後,用例如丙酮、甲醇及異丙醇等溶劑對基板進行了超聲清潔,接著進行了乾燥,且在紫外線(ultraviolet,UV)清潔器中使用UV進行了5分鐘的紫外線臭氧(ultraviolet ozone,UVO)處理。其後,將基板轉移至電漿清潔器(PT),且在真空下進行電漿處理以移除ITO功函數及殘餘膜之後,將基板轉移至熱沈積設備以進行有機沈積。 A glass substrate on which indium tin oxide (ITO) was coated as a thin film with a thickness of 1,500 angstroms (Å) was cleaned by ultrasonication with distilled water. After the cleaning with distilled water was completed, the substrate was ultrasonically cleaned with solvents such as acetone, methanol, and isopropyl alcohol, followed by drying and ultraviolet ozone (UVO) treatment for 5 minutes using UV in an ultraviolet (UV) cleaner. Thereafter, the substrate was transferred to a plasma cleaner (PT), and after plasma treatment under vacuum to remove the ITO work function and residual film, the substrate was transferred to a thermal deposition equipment for organic deposition.
在透明的ITO電極(陽極)上,形成了作為常見層的電洞注入層2-TNATA(4,4',4"-三[2-萘基(苯基)胺基]三苯基胺)及電洞轉移層NPB(N,N'-二(1-萘基)-N,N'-二苯基-(1,1'-聯苯基)-4,4'-二胺)。 On the transparent ITO electrode (anode), the hole injection layer 2-TNATA (4,4',4"-tri[2-naphthyl(phenyl)amino]triphenylamine) and the hole transfer layer NPB (N,N'-di(1-naphthyl)-N,N'-diphenyl-(1,1'-biphenyl)-4,4'-diamine) are formed as common layers.
如下,在電洞注入層2-TNATA及電洞轉移層NPB上熱真空沈積發光層。作為發光層,將如下表22中以化學式1闡述的一種類型的化合物及以化學式2闡述的一種類型的化合物在每一各別的供應源中沈積至400埃來作為主體,且藉由7%摻雜將Ir(ppy)3沈積為綠色磷光摻雜劑。其後,將浴銅靈(bathocuproine,BCP)沈積至60埃來作為電洞阻擋層,且在電洞阻擋層上將Alq3沈積至200埃來作為電子轉移層。最後,藉由將氟化鋰(LiF)沈積至10埃的厚度來在電子轉移層上形成電子注入層,且接著藉由 將鋁(Al)陰極沈積至1,200埃的厚度來在電子注入層上形成陰極,且因此,製造出有機電致發光裝置。 As follows, a light-emitting layer was thermally vacuum deposited on the hole injection layer 2-TNATA and the hole transfer layer NPB. As the light-emitting layer, a compound of a type as described in Chemical Formula 1 and a compound of a type as described in Chemical Formula 2 in Table 22 were deposited to 400 angstroms in each respective supply source as the main body, and Ir(ppy) 3 was deposited as a green phosphorescent dopant by 7% doping. Thereafter, bathocuproine (BCP) was deposited to 60 angstroms as a hole blocking layer, and Alq 3 was deposited to 200 angstroms on the hole blocking layer as an electron transfer layer. Finally, an electron injection layer was formed on the electron transfer layer by depositing lithium fluoride (LiF) to a thickness of 10 angstroms, and then a cathode was formed on the electron injection layer by depositing an aluminum (Al) cathode to a thickness of 1,200 angstroms, and thus, an organic electroluminescent device was manufactured.
同時,對於欲用於OLED製造中的每一種材料,在10-6托至10-8托下對製造OLED所需的所有有機化合物進行了真空昇華純化。 At the same time, for each material to be used in OLED manufacturing, all organic compounds required for OLED manufacturing were purified by vacuum sublimation at 10 -6 Torr to 10 -8 Torr.
<實驗例2>有機發光裝置的製造<Experimental Example 2> Fabrication of an organic light-emitting device
用蒸餾水超聲波對上面塗佈厚度為1,500埃的ITO來作為薄膜的玻璃基板進行了清潔。在用蒸餾水進行的清潔完成之後,用例如丙酮、甲醇及異丙醇等溶劑對基板進行了超聲清潔,接著進行了乾燥,且在UV清潔器中使用UV進行了5分鐘的UVO處理。其後,將基板轉移至電漿清潔器(PT),且在真空下進行電漿處理以移除ITO功函數及殘餘膜之後,將基板轉移至熱沈積設備以進行有機沈積。 A glass substrate on which ITO was coated with a thickness of 1,500 angstroms as a thin film was cleaned with distilled water ultrasonics. After the cleaning with distilled water was completed, the substrate was ultrasonically cleaned with solvents such as acetone, methanol, and isopropyl alcohol, followed by drying and UVO treatment for 5 minutes using UV in a UV cleaner. Thereafter, the substrate was transferred to a plasma cleaner (PT), and after plasma treatment under vacuum to remove the ITO work function and residual film, the substrate was transferred to a thermal deposition equipment for organic deposition.
在透明的ITO電極(陽極)上,形成了作為常見層的電洞注入層2-TNATA(4,4',4"-三[2-萘基(苯基)胺基]三苯基胺)及電洞轉移層NPB(N,N'-二(1-萘基)-N,N'-二苯基-(1,1'-聯苯基)-4,4'-二胺)。 On the transparent ITO electrode (anode), the hole injection layer 2-TNATA (4,4',4"-tri[2-naphthyl(phenyl)amino]triphenylamine) and the hole transfer layer NPB (N,N'-di(1-naphthyl)-N,N'-diphenyl-(1,1'-biphenyl)-4,4'-diamine) are formed as common layers.
如下,在電洞注入層2-TNATA及電洞轉移層NPB上熱真空沈積發光層。作為發光層,將如下表23中以化學式1闡述的一種類型的化合物及以化學式2闡述的一種類型的化合物在一個供應源中預混合且沈積至400埃來作為主體,且藉由7%摻雜將Ir(ppy)3沈積為綠色磷光摻雜劑。其後,將BCP沈積至60埃來作 為電洞阻擋層,且在電洞阻擋層上將Alq3沈積至200埃來作為電子轉移層。最後,藉由將氟化鋰(LiF)沈積至10埃的厚度來在電子轉移層上形成電子注入層,且接著藉由將鋁(Al)陰極沈積至1,200埃的厚度來在電子注入層上形成陰極,且因此,製造出有機電致發光裝置。 As follows, a light-emitting layer was thermally vacuum deposited on the hole injection layer 2-TNATA and the hole transfer layer NPB. As the light-emitting layer, a compound of a type as described in Chemical Formula 1 and a compound of a type as described in Chemical Formula 2 in Table 23 below were pre-mixed in one supply source and deposited to 400 angstroms as a main body, and Ir(ppy) 3 was deposited as a green phosphorescent dopant by 7% doping. Thereafter, BCP was deposited to 60 angstroms as a hole blocking layer, and Alq 3 was deposited to 200 angstroms on the hole blocking layer as an electron transfer layer. Finally, an electron injection layer was formed on the electron transfer layer by depositing lithium fluoride (LiF) to a thickness of 10 angstroms, and then a cathode was formed on the electron injection layer by depositing an aluminum (Al) cathode to a thickness of 1,200 angstroms, and thus, an organic electroluminescent device was manufactured.
同時,對於欲用於OLED製造中的每一種材料,在10-6托至10-8托下對製造OLED所需的所有有機化合物進行了真空昇華純化。 At the same time, for each material to be used in OLED manufacturing, all organic compounds required for OLED manufacturing were purified by vacuum sublimation at 10 -6 Torr to 10 -8 Torr.
對於如上製造的有機電致發光裝置,使用由邁克科學公司(McScience InC.)製造的M7000量測了電致發光(EL)性質,且利用量測結果,當標準亮度為6,000坎德拉/平方米(cd/m2)時,使用由邁克科學公司製造的壽命量測系統(M6000)量測了T90。 For the organic electroluminescent device manufactured as above, electroluminescence (EL) properties were measured using M7000 manufactured by McScience InC., and using the measurement results, T90 was measured using a life measurement system (M6000) manufactured by McScience InC. when the standard brightness was 6,000 cd/ m2 .
本揭露的有機電致發光裝置的性質如下表21至23中所示。作為參考,表22是在實驗例1的各別供應源中同時沈積兩種主體化合物的實例,表23是在實驗例2的預混合之後在一個供應源中沈積兩種發光層化合物的實例,且表21是在實驗例1中使用單一主體材料的實例。 The properties of the organic electroluminescent device disclosed in the present invention are shown in Tables 21 to 23 below. For reference, Table 22 is an example of depositing two host compounds simultaneously in separate supply sources in Experimental Example 1, Table 23 is an example of depositing two luminescent layer compounds in one supply source after premixing in Experimental Example 2, and Table 21 is an example of using a single host material in Experimental Example 1.
如自表21至表23看出,當在有機發光裝置的有機材料層中包含化學式1所示的雜環化合物與化學式2所示的雜環化合物二者時,獲得了更優越的效率及壽命效果。此種結果可能導致預測出:當同時包含所述兩種化合物時,會發生激發錯合體現象。 As can be seen from Tables 21 to 23, when the organic material layer of the organic light-emitting device includes both the heterocyclic compound shown in Chemical Formula 1 and the heterocyclic compound shown in Chemical Formula 2, superior efficiency and life effects are obtained. This result may lead to the prediction that when the two compounds are included at the same time, an excited complex phenomenon will occur.
激發錯合體現象是由於兩個分子之間的電子交換而釋放具有施體(p-主體)HOMO能級及受體(n-主體)LUMO能級大小的能量的現象。當兩個分子之間發生激發錯合體現象時,會發生逆向系統間交叉(RISC),且因此螢光的內部量子效率可提高至達100%。當具有合意的電洞轉移能力的施體(p-主體)及具有合意的電子轉移能力的受體(n-主體)用作發光層的主體時,電洞被注入至p-主體,且電子被注入至n-主體,且因此,驅動電壓可降低,此最終有助於壽命的提高。 The excited complex phenomenon is a phenomenon in which energy having the magnitude of the donor (p-host) HOMO energy level and the acceptor (n-host) LUMO energy level is released due to the exchange of electrons between two molecules. When the excited complex phenomenon occurs between two molecules, reverse intersystem crossing (RISC) occurs, and thus the internal quantum efficiency of fluorescence can be increased up to 100%. When a donor (p-host) having a desirable hole transfer ability and an acceptor (n-host) having a desirable electron transfer ability are used as hosts of the light-emitting layer, holes are injected into the p-host and electrons are injected into the n-host, and thus the driving voltage can be reduced, which ultimately contributes to an increase in lifetime.
另外,在預混合化合物之後,沈積了由多種類型的化合物形成的發光主體,且所述發光主體在本揭露中形成為一個沈積供應源(實驗例2,表23)。在本文中,避免多次沈積具有使薄膜表面的均勻性及薄膜性質維持原樣的優點。除此之外,在藉由簡化製程來降低整體製程成本的同時,可形成具有改善的效率、驅動電 壓及壽命的裝置。 In addition, after the premixed compounds, a luminescent body formed of various types of compounds is deposited, and the luminescent body is formed as a deposition supply source in the present disclosure (Experimental Example 2, Table 23). In this article, avoiding multiple depositions has the advantage of maintaining the uniformity of the film surface and the film properties as they are. In addition, while reducing the overall process cost by simplifying the process, a device with improved efficiency, driving voltage and life can be formed.
如自表22及表23看出,作為本申請案的化學式2所示的雜環化合物結構的稠合咔唑結構是包括兩個咔唑或一個咔唑以及一個雜環的結構,且藉此由於咔唑中的氮與雜原子中存在非共享電子對,因此具有強的電子施體性質。換言之,如自表22及表23看出,辨識出相較於當使用本申請案的對應於化學式1的雜環化合物及對應於化合物A至E的化合物(雙咔唑型;或者其中咔唑及雜環鍵合的結構)中的一者時,總驅動電壓/效率/壽命是優越的。 As can be seen from Tables 22 and 23, the fused carbazole structure of the heterocyclic compound structure shown in Chemical Formula 2 of the present application is a structure including two carbazoles or one carbazole and one heterocycle, and thereby has a strong electron donor property due to the presence of non-shared electron pairs between nitrogen and heteroatoms in carbazole. In other words, as can be seen from Tables 22 and 23, it is recognized that the total driving voltage/efficiency/lifetime is superior compared to when one of the heterocyclic compound corresponding to Chemical Formula 1 and the compounds corresponding to Compounds A to E (biscarbazole type; or a structure in which carbazole and heterocycle are bonded) of the present application is used.
另外,藉由對應於整個基礎骨架的π共軛的寬區域,相較於未稠合的咔唑化合物,獲得了更寬的HOMO能級區域,從而導致更寬的電洞分佈。因此,當驅動裝置時辨識出快速電洞轉移性質,且藉此,藉由降低驅動電壓而辨識出預期存在電流效率提高以及裝置臨限電壓降低的優點。 In addition, due to the wide region of π-conjugation corresponding to the entire basic skeleton, a wider HOMO energy level region is obtained compared to the unfused carbazole compound, resulting in a wider hole distribution. Therefore, when the device is driven, fast hole transfer properties are recognized, and thereby, by reducing the driving voltage, it is recognized that there is an expected advantage of improved current efficiency and reduced device critical voltage.
另外,作為化學式2的稠合咔唑具有其中五邊形或六邊形環藉由π-π鍵稠合的形式。此導致形成具有最小分子內畸變的結構(剛性結構),且因此獲得高熱穩定性(Td95:400℃或高於400℃,高Tg)。高熱穩定性是克服有機發光裝置(OLED)沈積製程的苛刻的高真空及高溫條件的有利因素,且當在長時間週期內驅動裝置時亦對裝置劣化有利。因此,看出,基於低電壓、高效率及高熱穩定性,作為化學式2所示的結構的稠合咔唑結構是可用作具有合意壽命的材料的基礎結構。 In addition, the fused carbazole as Chemical Formula 2 has a form in which pentagonal or hexagonal rings are fused by π-π bonds. This results in the formation of a structure with minimal intramolecular distortion (rigid structure), and thus high thermal stability (T d95 : 400° C. or higher, high T g ) is obtained. High thermal stability is an advantageous factor for overcoming the harsh high vacuum and high temperature conditions of the organic light-emitting device (OLED) deposition process, and is also advantageous for device degradation when the device is driven for a long period of time. Therefore, it can be seen that the fused carbazole structure as the structure shown in Chemical Formula 2 is a base structure that can be used as a material with a satisfactory life based on low voltage, high efficiency, and high thermal stability.
另外,如在表23中一樣進行預混合時,需要在混合中辨識材料中的每一者的獨特熱性質。在本文中,當自一個供應源沈積預混合主體材料時,材料的獨特熱性質可顯著影響包括沈積速率在內的沈積條件。當二或更多種類型的預混合材料之間的熱性質不相似且非常不同時,在沈積製程中可能無法維持可重複性及再現性,此意指不可能在一個沈積製程中製造出完全均勻的OLED。 In addition, when premixing is performed as in Table 23, the unique thermal properties of each of the materials in the mix need to be identified. In this context, when premixed host materials are deposited from one supply source, the unique thermal properties of the materials can significantly affect deposition conditions including deposition rate. When the thermal properties between two or more types of premixed materials are dissimilar and very different, repeatability and reproducibility may not be maintained in the deposition process, which means that it is impossible to produce completely uniform OLEDs in one deposition process.
鑑於以上情況,亦可依據分子結構的形狀來控制材料的熱性質,同時使用材料中的每一者的基礎結構與取代基的適當組合來調協材料的電性質。因此,除基礎結構之外,亦可使用化學式2中的各種取代基以及化學式2中的稠合咔唑的C-N鍵合來增強裝置效能,且可藉由控制材料中的每一者的熱性質來確保主體-主體之間的各種預混合沈積製程的多樣性。此具有確保使用三種、四種或更多種主體材料以及兩種化合物作為主體的預混合沈積製程的多樣性的優點。 In view of the above, the thermal properties of the material can also be controlled according to the shape of the molecular structure, while the electrical properties of the material can be adjusted using the appropriate combination of the basic structure and substituents of each of the materials. Therefore, in addition to the basic structure, various substituents in Chemical Formula 2 and the C-N bond of the fused carbazole in Chemical Formula 2 can also be used to enhance device performance, and the diversity of various pre-mixed deposition processes between hosts can be ensured by controlling the thermal properties of each of the materials. This has the advantage of ensuring the diversity of pre-mixed deposition processes using three, four or more host materials and two compounds as hosts.
另外,當驅動OLED時,由於在長時間週期內進行裝置驅動引起的非輻射性發射所產生的熱能及電流阻力所產生的熱能,裝置內部在長時間週期內暴露於各種形式的熱。與金屬不同,有機材料的熱阻(thermal resistance)非常低,且因此,需要藉由準確的熱穩定性資料來確保材料的熱穩定性。另外,亦在高真空狀態中於高溫下執行OLED沈積製程,且具有低熱穩定性的材料已在沈積製程中劣化,使得其不可能作為OLED來驅動。因此,檢查形成裝置的材料的熱穩定性是構建OLED的非常重要的準備工作。 In addition, when driving an OLED, the inside of the device is exposed to various forms of heat over a long period of time due to heat energy generated by non-radiative emission caused by device driving over a long period of time and heat energy generated by current resistance. Unlike metals, organic materials have very low thermal resistance, and therefore, accurate thermal stability data is required to ensure the thermal stability of the material. In addition, the OLED deposition process is also performed at high temperature in a high vacuum state, and materials with low thermal stability have deteriorated in the deposition process, making it impossible to drive as an OLED. Therefore, checking the thermal stability of the material forming the device is a very important preparation for building an OLED.
化學式2中闡述的稠合咔唑結構是一種其中藉由-鍵而強連接的諸多五邊形/六邊形環進行稠合結構,且具有剛性結構,且因此具有100℃或高於100℃的高Tg及400℃或高於400℃的非常高的Td(95%)。看出,此為一種足以承受OLED沈積製程的苛刻的高真空/高溫狀態且即使當在長時間週期內驅動裝置時亦具有足夠的穩定性以防止裝置劣化的材料。 The fused carbazole structure described in Formula 2 is one in which - Many pentagonal/hexagonal rings that are strongly bonded form a fused structure and have a rigid structure, and therefore have a high Tg of 100° C. or higher and a very high Td (95%) of 400° C. or higher. It is seen that this is a material that is strong enough to withstand the harsh high vacuum/high temperature conditions of the OLED deposition process and has sufficient stability to prevent device degradation even when the device is driven for a long period of time.
圖4至圖21是使用梅特勒-托利多(Mettler Toledo)的熱重分析(Thermogravimetric Analysis,TGA)/差示掃描量熱法(Differential Scanning Calorimetry,DSC)裝置量測的化學式2所示的每一材料的熱分析資料。藉由加熱將溫度升高至達600℃來量測所測得的Td95,以使得溫度自30℃以每分鐘10開(K)升高。在例如對應於化學式2的玻璃轉變溫度(Tg)、結晶溫度(Tc)、熔化溫度(Tm)及分解溫度(Td/95%)等熱性質中,辨識玻璃轉變溫度及分解溫度,以首先辨識裝置在長期驅動及高真空沈積製程中的穩定性。 FIG. 4 to FIG. 21 are thermal analysis data of each material shown in Chemical Formula 2 measured using a Mettler Toledo Thermogravimetric Analysis (TGA)/Differential Scanning Calorimetry (DSC) device. The measured Td 95 is measured by heating the temperature up to 600°C so that the temperature increases from 30°C at 10 K per minute. Among the thermal properties such as the glass transition temperature (Tg), crystallization temperature (Tc), melting temperature (Tm) and decomposition temperature (Td/95%) corresponding to Chemical Formula 2, the glass transition temperature and the decomposition temperature are identified to first identify the stability of the device in a long-term drive and high vacuum deposition process.
圖4及圖5是示出本申請案的化合物2-19的熱穩定性的曲線圖,圖6及圖7是示出本申請案的化合物2-20的熱穩定性的曲線圖,圖8及圖9是示出本申請案的化合物2-22的熱穩定性的曲線圖,圖10及圖11是示出本申請案的化合物2-8的熱穩定性的曲線圖,圖12及圖13是示出本申請案的化合物2-18的熱穩定性的曲線圖,圖14及圖15是示出本申請案的化合物2-79的熱穩定性的曲線圖,且圖16及圖17是示出本申請案的化合物2-123 的熱穩定性的曲線圖。 Figures 4 and 5 are graphs showing the thermal stability of compound 2-19 of the present application, Figures 6 and 7 are graphs showing the thermal stability of compound 2-20 of the present application, Figures 8 and 9 are graphs showing the thermal stability of compound 2-22 of the present application, Figures 10 and 11 are graphs showing the thermal stability of compound 2-8 of the present application, Figures 12 and 13 are graphs showing the thermal stability of compound 2-18 of the present application, Figures 14 and 15 are graphs showing the thermal stability of compound 2-79 of the present application, and Figures 16 and 17 are graphs showing the thermal stability of compound 2-123 of the present application.
另外,圖18及圖19是示出化合物A的熱穩定性的曲線圖,且圖20及圖21是示出化合物C的熱穩定性的曲線圖。 In addition, Figures 18 and 19 are graphs showing the thermal stability of compound A, and Figures 20 and 21 are graphs showing the thermal stability of compound C.
在示出圖4至圖21的熱穩定性的曲線圖中,Td95是當在施加溫度之後質量的95%得到保持時量測溫度的點,且高的Td95意味著在高溫下穩定。 In the graphs showing thermal stability of FIGS. 4 to 21 , Td 95 is the point at which the temperature is measured when 95% of the mass is maintained after the temperature is applied, and a high Td 95 means stability at high temperatures.
如藉由將圖4至圖17與圖18至圖21進行比較辨識出,在具有雙咔唑結構的化合物A(圖18及圖19)及化合物C(圖20及圖21)中,Td95被測量為低至400℃或低於400℃,此導致相較於稠合咔唑化合物而言較低的熱穩定性。 As can be recognized by comparing FIGS. 4 to 17 with FIGS. 18 to 21 , in compound A ( FIGS. 18 and 19 ) and compound C ( FIGS. 20 and 21 ) having a biscarbazole structure, Td 95 was measured to be as low as 400° C. or lower, resulting in lower thermal stability compared to the condensed carbazole compound.
因此,辨識出包含化學式1所示的化合物與化學式2所示的化合物二者的基礎結構在製造具有低電壓/高效率目標的裝置或具有高效率/長壽命或低電壓/長壽命性質的OLED中是足夠有效的。 Therefore, it is recognized that the basic structure including both the compound shown in Chemical Formula 1 and the compound shown in Chemical Formula 2 is sufficiently effective in manufacturing a device with a low voltage/high efficiency target or an OLED with high efficiency/long life or low voltage/long life properties.
100:基板 100: Substrate
200:陽極 200: Yang pole
300:有機材料層 300: Organic material layer
400:陰極 400: cathode
Claims (15)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020180172503A KR102261984B1 (en) | 2018-12-28 | 2018-12-28 | Organic light emitting device, manufacturing method of the same and composition for organic layer of organic light emitting device |
| KR10-2018-0172503 | 2018-12-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202033741A TW202033741A (en) | 2020-09-16 |
| TWI841655B true TWI841655B (en) | 2024-05-11 |
Family
ID=71128250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW108148067A TWI841655B (en) | 2018-12-28 | 2019-12-27 | Organic light emitting device, manufacturing method of the same and composition for organic material layer of organic light emitting device |
Country Status (3)
| Country | Link |
|---|---|
| KR (1) | KR102261984B1 (en) |
| TW (1) | TWI841655B (en) |
| WO (1) | WO2020138959A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115918301A (en) * | 2020-07-17 | 2023-04-04 | 株式会社Lg化学 | organic light emitting device |
| WO2022031028A1 (en) * | 2020-08-04 | 2022-02-10 | 주식회사 엘지화학 | Novel compound and organic light emitting device using same |
| CN114599647B (en) * | 2020-09-28 | 2024-10-18 | Lt素材株式会社 | Heterocyclic compound, organic light-emitting component comprising same, and composition for organic material layer of organic light-emitting component |
| WO2022086296A1 (en) * | 2020-10-22 | 2022-04-28 | 주식회사 엘지화학 | Organic light-emitting device |
| KR20220145292A (en) * | 2021-04-21 | 2022-10-28 | 주식회사 엘지화학 | Organic light emitting device |
| CN113620959B (en) * | 2021-08-10 | 2022-07-26 | 陕西莱特迈思光电材料有限公司 | Organic compound, and organic electroluminescent device and electronic device using the same |
| CN113943299B (en) * | 2021-12-01 | 2023-03-14 | 西安瑞联新材料股份有限公司 | Synthesis method of indolo [2,3-B ] carbazole compound |
| WO2023125498A1 (en) * | 2021-12-27 | 2023-07-06 | 浙江光昊光电科技有限公司 | Organic compound, mixture and composition comprising same, organic electronic device, and applications of compound |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20170111387A (en) * | 2016-03-28 | 2017-10-12 | 에스에프씨 주식회사 | Organic light-emitting compounds and Organic light-emitting device comprising the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356429A (en) | 1980-07-17 | 1982-10-26 | Eastman Kodak Company | Organic electroluminescent cell |
| US20160268516A1 (en) * | 2013-08-16 | 2016-09-15 | Konica Minolta, Inc. | Organic electroluminescent element, electronic device, light emitting device, and light emitting material |
| WO2016015810A1 (en) * | 2014-07-29 | 2016-02-04 | Merck Patent Gmbh | Materials for organic electroluminescent devices |
| KR101961334B1 (en) * | 2016-10-25 | 2019-03-22 | 주식회사 엘지화학 | Novel hetero-cyclic compound and organic light emitting device comprising the same |
| KR101943428B1 (en) * | 2017-03-24 | 2019-01-30 | 엘티소재주식회사 | Organic light emitting device and composition for organic layer of organic light emitting device |
| KR20180108425A (en) * | 2017-03-24 | 2018-10-04 | 희성소재 (주) | Heterocyclic compound and organic light emitting device comprising the same |
-
2018
- 2018-12-28 KR KR1020180172503A patent/KR102261984B1/en active Active
-
2019
- 2019-12-26 WO PCT/KR2019/018478 patent/WO2020138959A1/en not_active Ceased
- 2019-12-27 TW TW108148067A patent/TWI841655B/en active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20170111387A (en) * | 2016-03-28 | 2017-10-12 | 에스에프씨 주식회사 | Organic light-emitting compounds and Organic light-emitting device comprising the same |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020138959A1 (en) | 2020-07-02 |
| TW202033741A (en) | 2020-09-16 |
| KR20200082176A (en) | 2020-07-08 |
| KR102261984B1 (en) | 2021-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI795694B (en) | Heterocyclic compound, organic light emitting device comprising same, composition for organic layer of organic light emitting device and manufacturing method of organic light emitting device | |
| TWI703201B (en) | Organic light emitting device, method for manufacturing the same, and composition for organic material layer of organic light emitting device | |
| JP7479697B2 (en) | Heterocyclic compound, organic light-emitting device containing the same, composition for organic layer of organic light-emitting device, and method for producing organic light-emitting device | |
| TWI711686B (en) | Organic light emitting device, method for manufacturing the same, and composition for organic material layer of organic light emitting device | |
| TWI841655B (en) | Organic light emitting device, manufacturing method of the same and composition for organic material layer of organic light emitting device | |
| TWI735047B (en) | Organic light emitting device, composition and manufacturing method of organic light emitting device | |
| CN113939923B (en) | Organic light emitting device, method for manufacturing the same, and composition for organic material layer of organic light emitting device | |
| EP3683217A1 (en) | Heterocyclic compound and organic light emitting element comprising same | |
| TW202214819A (en) | Heterocyclic compound, organic light emitting device comprising the same and composition for organic material layer of organic light emitting device | |
| TWI825377B (en) | Heterocyclic compound, organic light emitting device comprising the same and composition for organic material layer of organic light emitting device | |
| TW202219241A (en) | Organic light emitting device and composition for forming organic material layer | |
| TWI831900B (en) | Organic light emitting device, manufacturing method of the same and composition for organic material layer of organic light emitting device | |
| TWI858277B (en) | Heterocyclic compound and organic light emitting device comprising the same | |
| TWI886320B (en) | Heterocyclic compound, organic light emitting device comprising the same and composition for organic material layer of organic light emitting device | |
| CN115515950A (en) | Heterocyclic compound, organic light-emitting device including the same, method of preparing the same, and composition for organic layer | |
| TWI857156B (en) | Heterocyclic compound, organic light emitting device, composition for organic light emitting device and manufacturing method of organic light emitting device | |
| CN116075507B (en) | Heterocyclic compound and organic light-emitting element containing the same | |
| TW202311237A (en) | Heterocyclic compound, organic light emitting device comprising same and composition for organic layer | |
| TWI833856B (en) | Organic light emitting device, method for manufacturing the same and composition for organic material layer | |
| CN112020502A (en) | Heterocyclic compound, organic light-emitting element including the same, method for producing the same, and composition for organic layer of organic light-emitting element | |
| CN112420964B (en) | Organic light emitting device, method for manufacturing the same, and composition for organic material layer | |
| CN113950474B (en) | Heterocyclic compound and organic light-emitting device comprising the same | |
| KR102737390B1 (en) | Heterocyclic compound, organic light emitting device and composition for organic layer comprising the same | |
| TWI853133B (en) | Heterocyclic compound, organic light emitting device comprising the same and composition for organic material layer of organic light emitting device | |
| TW202521517A (en) | Heterocyclic compound, organic light emitting device comprising the same and composition for organic layer |